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Abbreviation
Aa aminoacid 
Ago argonaute 
AICD activation induced cell 
death  
AID activation-induced cytidine 
deaminase  
AIRE autoimmune regulator 
AKT protein kinase B 
ALPS autoimmune 
lymphoproliferative 
syndrome 
AMD ARE-mediated decay 
ANA anti-nuclear antibody 
AP1 activator binding protein 1 
APC antigen presenting cell 
ARE AU-rich element 
ARE-BP ARE-binding protein 
BAFF B cell activator factor 
BAFF-R BAFF receptor 
BCR B cell receptor 
CBL-B casitas B-lineage 
lymphoma 
CCL CC-chemokine ligand 
CCR CC-chemokine receptor 
CD40L CD40 ligand 
CMP common myeloid 
precursors 
CSR class switch recombination 
cTEC  cortical thymic epithelial 
cell 
CTL cytotoxic T lymphocyte 
CTLA-4 cytotoxic T-lymphocyte-
associated antigen 4  
CXCL CXC-chemokine ligand 
CXCR CXC-chemokine receptor 
DAMP damage associated 
molecular patterns 
DC dendritic cell 
DN double negative 
DNA deoxyribonucleic acid 
DP double positive 
ds-DNA double-stranded DNA 
ds-siRNA double-stranded siRNA 
EBV epstein-barr virus 
eIF4G eukaryotic initiation factor 
4G  
EJC  exon-junction complex 
ENU ethylnitrosourea 
ERK extracellular signal-
regulated kinase 
FasL Fas ligand 
FcR Fc receptor 
FcγR Fc receptor for IgG 
FDC follicular dendritic cell 
FO follicular 
GC germinal center 
GDP guanosine diphosphate 
GEF guanine nucleotide 
exchange factor 
GM-CSF granulocyte-macrophage 
colony-stimulating factor 
GTP guanosine triphosphate 
HLA human leukocyte antigen 
ICOS T cell inducible co-
stimulator 
ICOSL ICOS ligand 
Ig immunoglobulin 
IGF insulin-like growth factor 
IKK1 IκB kinase-1/α 
IL interleukin 
INF interferon 
IPEX immune dysregulation, 
polyendocrynopathy, 
enteropathy, X-linked 
syndrome 
IκB inhibitor of NF-κB 
LPS lipopolysaccharide 
LT-HSC long term-hematopoietic 
stem cell 
LT-α lymphotoxin-α 
mAb monoclonal antibody 
MAPK mytogen-activated protein 
kinase 
MBL mannose-binding lectin 
MHC major histocompatibility 
complex 
miRNA microRNA 
Mnab membrane-associated 
nucleic acid binding protein 
MPEC memory precursors 
effector cell 
MPP multipotent progenitor 
mRNA messenger RNA 
mRNP mRNA-protein complexes 
mTEC medullary tymic epithelial 
cell 
MZ marginal zone 
ncRNA non coding RNA 
NF-κB nuclear factor-κB 
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NFAT nuclear factor of activated 
T cells 
NK natural killer 
NMD nonsense-mediated decay  
Nt nucleotide 
PAMP pathogen associated 
molecular pattern 
PB P-body 
PD-1 programmed death 1  
PI3K phosphoinositide-3 kinase 
PKC protein kinase C 
PRR pattern-recognition 
receptor 
RAG recombination-activating 
gene 
RISC RNA-induced silencing 
complex 
RNA ribonucleic acid 
RNAi RNA interference 
San sanroque 
SG stress granule 
SHM somatic hypermutation 
siRNA short-interfering RNA 
SL-HSC short-lived hematopoietic 
stem cell 
SLC surrogate light chain 
SLE systemic lupus 
erythematosus 
SLEC short-lived effector cell 
snRNA small nuclear RNA 
SOS son of sevenless  
SP single positive 
TCM T central memory 
TCR T cell receptor 
Tcra T cell receptor locus α 
Tcrb T cell receptor locus β 
TD thymus-dependent 
TEM T effector memory cell 
TFH T follicular helper cell 
Th T helper cell 
Th2 CD4 T helper type 2 cell 
TI thymus-independent 
TLR toll-like receptor 
TNF tumor necrosis factor 
Treg T regulatory cell 
TTP tristetraprolin 
UTR untranslated region 
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Summary 
The immune system of mammals and birds has the potential to generate millions of 
cellular receptors that can sense invading pathogens. On lymphocytes, this large 
range of specificities has the potential to recognize components of the own organism, 
and several self-tolerance mechanisms have evolved to control the activity of the 
autoreactive cells. Defects in tolerance pathways have been described in several 
autoimmune diseases. Systemic lupus erythematosus is a multi-organ autoimmune 
disorder which has been linked with defects in several components of the immune 
system and several genetic alterations have been shown to predispose to lupus in 
humans. Recently, abnormal expansion of the follicular helper T cell subset in 
humans has been associated with systemic lupus erythematosus, and in mice the 
RNA-binding protein Roquin was proposed to exert an important role in preventing 
aberrant activation of these cells.  
To examine its precise mechanism-of-action in the immune system we generated a 
Roquin conditional knockout allele (Paper II). Complete loss of Roquin caused 
perinatal lethality with spinal cord defects and insufficiently ventilated lungs. 
Surprisingly, loss of Roquin specifically in the T cell compartment, in the entire 
hematopoietic system, or in the whole organism, did not lead to autoimmunity. This 
result is in contrast to the sanroque mouse model, in which a point mutation in the 
Roquin gene causes aberrant follicular helper T cell expansion and development of a 
lupus-like autoimmune disorder. Specific ablation of Roquin in T and in B cells, 
however, caused specific perturbations in the immune homeostasis. Loss of Roquin 
in T lymphocytes leads to expansion of effector-like CD8 T cells which phenotypically 
resemble short-lived effector cells. Moreover, expansion of eosinophils and 
macrophages/monocytes was also observed following deletion of Roquin in T cells. 
Furthermore, we analyzed the effects of Roquin ablation in the B cell compartment. 
In these mice immune homeostasis was impaired. In particular, expansion of total B, 
regulatory T, activated CD4 and CD8 T, and germinal center B cells was described. 
These results indicate that in the hematopoietic system Roquin is instrumental in 
maintaining immune homeostasis, and that loss of Roquin alone is not sufficient to 
break tolerance to self. 
Recently, polymorphisms and mutations in the gene encoding for A20 (Tnfaip3), a 
negative regulator of NF-κB pathway, have been described in lupus patients. To 
study B cell intrinsic functions of A20 during B cell development and activation, and 
to understand its possible role in preventing autoimmune manifestations, we 
employed a conditional Tnfaip3 knockout mouse model (Paper I). Ablation of A20 in 
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B lymphocytes reduced their activation threshold and increased their proliferation 
and survival in response to pathogenic stimuli. Furthermore, together with 
autoimmune pathology and inflammation, we observed increased levels of class-
switched auto-antibodies in old A20 B cell specific knock out mice. In conclusion, 
specific loss of A20 in B cells is sufficient to cause an inflammatory syndrome and to 
break tolerance to self.  !
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Introduction !
1 The RNA-binding protein Roquin 
Control of mRNA stability has emerged as a key mechanism to control gene 
expression, and RNA-binding proteins play important roles in maintaining immune 
homeostasis. Vinuesa and colleagues [5], [6], [7] described the RNA-binding protein 
Roquin [8], a novel RING-type E3 ubiquitin ligase family member that also contains a 
CCCH-type zinc finger domain. A mouse strain harboring a single point mutation in 
Roquin, the sanroque mouse, is characterized by a severely compromised immune 
system and it develops a spontaneous  lupus-like autoimmune syndrome at young 
age. In the sanroque mice, the hypomorphic mutant of Roquin (Roquinsan) fails to 
control the expression of the T cell inducible co-stimulator ICOS [6], an important 
regulator of T lymphocyte activation. Ectopic expression of ICOS on naive T cells 
was proposed to induce spontaneous differentiation and/or expansion of follicular 
helper T (TFH) cells. The TFH cells in turn trigger germinal center B cell responses to 
self-antigens with ensuing autoantibody production and autoimmunity [5], [6], [9]. 
According to this model, inhibiting ICOS expression on naive T cells represents a key 
checkpoint in the maintenance of immunological tolerance.  
1.1 Overview of Roquin 
Roquin is a 1130aa long intracellular protein. It is highly conserved from 
invertebrates to mammals and its transcript has been ubiquitously detected in 
different organs [5]. The gene encoding for Roquin, Rc3h1, is located on 
chromosome 1 in both humans and mice. The amino-terminus of the protein harbors 
a RING finger domain suggesting E3-ubiquitin ligase activity. Carboxy-terminal to the 
RING-finger follow a so-called ROQ domain and the CCCH-zinc finger domains 
responsible for Roquin’s ability to bind RNA [8]. The ROQ domain is a ~ 200 aa long, 
highly conserved domain (94% identity at the protein level) present only in Roquin 
and its paralogue membrane-associated nucleic acid binding protein (Mnab, encoded 
by Rc3h2). In mammals the two proteins share a very similar amino-terminus, while 
they are characterized by divergent carboxy-termini (Figure 1). The carboxy-terminus 
of Mnab contains a hydrophobic region which is completely absent from Roquin and 
which might target the protein to the plasmamembrane [10]. The carboxy-terminus of 
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Roquin instead is characterized by the presence of a coiled-coil domain being a 
potential site for homo/heteroligomerization (Figure 1).  
 
 
 
 
 
Recently it has been demonstrated that Roquin can interact with components of both 
the P-bodies (PB) and stress granule (SG) pathways [8]. Processing bodies (PB) are 
cytoplasmic foci which are sites of mRNA degradation [11] and translational 
repression [12]. These foci contain high concentrations of proteins involved in mRNA 
degradation and microRNA components, while stress granules are structures 
containing mRNAs that are translationally arrested in response to a wide range of 
environmental stresses [13]. Roquin overexpressed in ex vivo isolated CD4 T cells 
colocalizes with Rck protein, which is a marker for PBs. However, arsenite-treatment 
of CD4 T cells leads to formation of SGs in the cytoplasm, and in this case Roquin 
mainly colocalizes with SGs while it remains associated with PBs only in 5.5% of the 
stressed cells [8]. Interestingly, the carboxy-terminus of Roquin showed a high 
frequency of glutamine and asparagine residues. As reported for other PB-
components [14], this region of Roquin is important for its correct localization to the 
PBs, but not to arsenite-induced SGs. 
PBs are structures highly enriched for proteins involved in mRNA decay, including 
the decapping complex Dcp1/Dcp2, the enhancer of decapping Edc4, the RNA 
helicase Rck, the exonuclease Xrn1 and the deadenylase Ccr4. Moreover they 
contain proteins involved in the nonsense-mediated decay (NMD) and the microRNA 
pathways (see chapter 1.3.1). It has been shown that Roquin can interact with 
several of these components, namely Rck, Edc4 and Dcp1a, and this physical 
interaction has been proposed to be important for ICOS repression [8].  
Roquin’s ability to bind RNA and to localize to PBs, but not SGs, is necessary to 
allow Roquin to destabilize ICOS mRNA by binding to its 3’UTR inducing mRNA 
decay [6, 8]. A binding site of Roquin to the ICOS mRNA has been identified in the 
region between 100 and 200 base pairs downstream of the stop codon of ICOS. 
Figure 1 : comparison of 
the domain organization of 
Roquin (Rc3h1, upper 
schematic drawing, 
transcript ID 
ENSMUST00000161609 ) 
and Mnab (Rc3h2, lower 
schematic drawing, 
transcript ID 
ENSMUST00000100143) 
proteins. Numbers indicate 
aa according to Ensembl 
annotation. 
Introduction !
! 3!
However, the degree of ICOS repression by Roquin increased with length of the 
ICOS 3’UTR, indicating that multiple sites on ICOS 3’UTR might be necessary to 
induce full repression by Roquin [8].  
The precise mechanism-of-action of Roquin has not been precisely elucidated yet. A 
previous report indicated that Roquin induces mRNA degradation in a miR-101 
dependent manner [6]. A more recent publication, however, demonstrates that 
Roquin’s action on ICOS mRNA is independent of miRNAs or miRISC formation, 
since Roquin can still induce the downregulation of ICOS mRNA or ICOS 3’UTR in 
Dicer-/- mouse embryonic fibroblasts (MEFs) and in mouse Ago1-4-/- embryonic stem 
cell lines [8]. 
Roquin and Mnab also contain a RING-finger domain which might mediate E3 
ubiquitin ligase activity. In mammals a function for Roquin or Mnab as E3 ubiquitin 
ligases has not yet been demonstrated. In C. elegans, however, the Rc3h1 homolog 
RLE-1 has been found to regulate the lifespan of the worm by ubiquitinating and 
inducing the degradation of the transcriptional activator DAF-16 [15]. DAF-16, the 
homolog of mammalian Foxo3a, is a transcriptional activator that regulates longevity 
and stress resistance in C.elegans and is highly regulated at the post-translational 
level. Activation of AKT by the Insulin/IGF pathway induces phosphorylation of DAF-
16 preventing its nuclear translocation and transcriptional activity. Moreover, DAF-16 
proteins levels are controlled through the proteasome pathway. RLE-1 can physically 
interact with DAF-16 through its carboxy-terminus, while the RING finger domain 
mediates ubiquitination of DAF-16 inducing its degradation thereby shortening C. 
elegans lifespan.  
1.2 The sanroque mouse strain 
The autoimmune sanroque mouse strain [5] is characterized by the presence of a 
single point mutation leading to the exchange of methionine 199 for arginine (M199R) 
in the ROQ domain of Roquin. This strain was generated by treating C57BL/6 mice 
with ethylnitrosourea (ENU), a chemical compound that introduces point mutations 
into the germline of mice at a frequency of one mutation per 0.5 megabases. 
Sanroque homozygous mice develop an autoimmune syndrome, which resembles 
systemic lupus erythematosus (SLE) in human patients. Rc3h1san/san animals develop 
anti-nuclear antibodies (ANAs) at an age of 6-7 (females) or 8-16 (males) weeks. The 
mice display also other features typical of SLE, for example the production of high 
affinity anti-dsDNA antibodies, focal proliferative glomerulonephritis, necrotizing 
hepatitis, anemia, autoimmune thrombocytopenia, splenomegaly and 
lymphadenopathy. Moreover, sanroque mice develop high titers of immunoglobulins 
Introduction !
! 4!
of all T-dependent isotypes. Despite normal T and B cell development, effector-like 
CD4 and CD8 T cells accumulate in the periphery of adult mice.  
In the Rc3h1san/san mice the M199R is a hypomorphic rather than null mutation, since 
forced expression of Rc3h1M199R in san/san T cells induced an intermediate 
downregulation of ICOS on the cell surface compared to Roquinwt [5]. The M199R 
substitution most likely disturbs the predicted alpha-helical structure of the ROQ 
domain by introducing a positively charged arginine residue, but it does not 
destabilize the protein, since normal levels of Roquin have been detected by western 
blot in ex vivo isolated san/san thymocytes [5]. The analysis of the sanroque mouse 
strain revealed the critical function of Roquin and its ROQ domain in regulating ICOS 
expression on the T cell surface [5]. However, the M199R mutation does not impair 
the ability of Roquin to bind ICOS mRNA, but it rather increases  it [16]. It has been 
instead suggested that the M199R substitution alters the ability of Roquin to interact 
with as yet unknown critical effector proteins [7].  
Mice homozygous for the sanroque mutation display increased levels of ICOS on 
their T cells. This deregulation was proposed to cause accumulation of T cells within 
the B cell follicle and to induce germinal center reactions to self-antigens. Moreover, 
the sanroque mice are characterized by an overrepresented  TFH compartment within 
the CD4+ T cells. Both increased ICOS expression and TFH expansion were shown to 
be caused by a T cell intrinsic defect of Roquin [9]. Tsan/san  cells inappropriately 
provide help to self-reactive B cells within the GC reaction (see chapter 3.2). 
Formation of spontaneous GC is critical for the pathogenesis of the autoimmune 
syndrome in sanroque mice, since loss of one allele of the GC master regulator Bcl6, 
which significantly prevents the development of the germinal centers, reduces the 
lupus-like phenotype [9]. Moreover, impaired CD4 T cell help to GC B cells caused 
by ablation of SAP, an adaptor protein downstream of the T cell receptor (TCR), also 
prevents GC formation and ameliorates the autoimmune phenotype of the sanroque 
mice. In particular, impaired GC formation in Rc3h1san/sanSAP-/- mice rescued 
autoantibodies production (including ANA and anti-dsDNA antibodies) and 
immunocomplex deposition in the kidneys ameliorating the renal pathology. However, 
features of the sanroque mice like hypergammaglobulinemia, splenomegaly and 
lymphadenopathy are not rescued by loss of GC formation, indicating that a non-TFH 
mediated mechanism contributes to the disease development in these animals [9].  
CD28 is a T cell-surface receptor that delivers signals required for full activation of 
naive T cells in addition to TCR engagement by antigen. The ligands of CD28, B7.1 
and B7.2 are only upregulated on antigen-presenting cells in response to infections, 
thereby preventing T cell activation by innocuous or self-antigens. Interestingly, Icos 
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emerged by duplication of the more ancient Cd28 gene and both are highly similar in 
protein sequence. Moreover, both CD28 and ICOS activate PI3K signaling and 
sustain TCR-induced gene expression and cytokine synthesis [17]. Under normal 
physiological conditions the CD28 and ICOS pathways have sequential and distinct 
functions, since ICOS is only expressed on activated T cells. In T cells with intact 
Roquin function ICOS is inducibly expressed subsequent to TCR/CD28 co-
stimulation and can then be triggered through its constitutively expressed ligand 
(ICOSL). In sanroque mice, however, ectopically expressed ICOS receives the co-
stimulatory signal through binding ICOSL and can therefore substitute for CD28 
signaling on naive T cells. These events eliminate a critical checkpoint designed to 
discriminate between self and non-self. It has been proposed that, by regulating 
ICOS mRNA stability, Roquin prevents ICOS to bypass the requirement for CD28 
during the early phase of an immune response, including primary antibody responses 
and GC formation. Roquin's main function was therefore proposed to ensure that the 
overlapping functions of Cd28 and Icos are well compartmentalized [18].     
1.3 Control of mRNA stability in the immune system 
1.3.1 Pathways of mRNA degradation 
In eukaryotes different pathways of RNA degradation remove RNA molecules from 
the cells. These pathways determine the physiological mRNA turnover, enable 
processing of RNA precursors and ensure quality control of the transcripts. RNA 
processing is essential for the maturation of many different classes of cellular RNAs 
that are synthesized as larger precursors, as microRNAs (miRNAs) or small nuclear 
RNAs (snRNAs) [19]. Pathways of quality control instead recognize incorrectly 
synthesized mRNAs or ncRNAs both in the nucleus and cytoplasm. In the nucleus, 
mRNA-protein complexes (mRNPs), which assemble immediately after transcription, 
are subjected to surveillance. Aberrant mRNAs are recognized and are either 
degraded by the nuclear exosome complex from the 3' end or by 5’ to 3’ 
exoribonucleases. In the cytoplasm, instead, the best studied mRNA quality control 
system is represented by the nonsense-mediated decay (NMD) pathway. The NMD-
pathway identifies the formation of premature stop codons. In particular, the NMD 
machinery recognizes the presence of a stop codon in a position that is located 5' to 
exon-exon junction complexes (EJCs). EJCs are ribonucleoprotein complexes that 
are deposited on mRNAs during splicing at the junction of two exons. Translation of 
mRNAs terminates at the stop codon, which in appropriate transcripts is not followed 
by an EJC.  
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Two main classes of enzymes mediate mRNA degradation, the endoribonucleases 
and the exoribonucleases. The former enzymes cleave mRNAs internally, while the 
latter degrade mRNAs either from the 5’ or the 3’ end. Both ends of eukaryotic 
mRNAs are normally protected from exoribonuclease activity by specific terminal 
structures: a m7GpppN cap at the 5’ end and a poly(A) tail at the 3’end. Removal of 
these terminal modifications requires the activation of specific deadenylating and 
decapping enzymes, and these processes are rate limiting for the mRNA decay 
pathway [20].  
Three main pathways of mRNA decay have been described: 1) Deadenylation-
dependent mRNA decay; 2) Deadenylation-independent mRNA decay; 3) 
Endoribonuclease-mediated mRNA decay (Figure 2).  
Most of the transcripts undergo deadenylation-dependent mRNA decay. 
Deadenylating enzymes, as the CCR4-NOT complex, shorten the poly(A)tail of the 
transcript [21]. Only when this process is complete, the exosome, which in 
eukaryotes is a complex composed of 9 different proteins, can completely degrade 
the mRNA from the 3’ end through its 3’ to 5’ exoribonuclease activity [22]. 
Alternatively, removal of the 5’ cap on the mRNA by the decapping machinery, 
represented by the Dcp1/Dcp2 complex which hydrolyzes the m7GpppN cap into 
m7GDP and a monophosphate 5’ RNA end, exposes an unprotected 5’ end  allowing 
the 5’ to 3’ exoribonuclease Xrn1 to degrade the RNA. In this case, the decapping 
machinery is recruited to the targeted mRNA through interaction with the Lsm1-7 
complex which binds partially deadenylated mRNA [23]. The exoribonuclease Xrn1, 
however, can degrade some mRNA substrates without prior deadenylation, giving 
rise to the deadenylation-independent mRNA decay pathway [24]. In yeasts, Rps28b 
regulates the half-life of its own mRNA by interacting with secondary structures of the 
3’ untranslated region (3’ UTR) and with the enhancer of decapping Edc3. In this 
case the process of decapping is not induced by deadenylation but by the presence 
of Edc3, which recruits the decapping machinery to the targeted mRNA [25].  
The third pathway of mRNA decay is mediated by endonucleases [26]. 
Endoribonucleases can hydrolyze ester-bonds within the RNA creating two 
fragments which lack the m7GpppN cap or the poly(A) tail and are than susceptible to 
exoribonuclease activity. Since both cap and poly(A) tail are structures necessary to 
initiate translation, none of the fragments generated by these different decay 
pathways should be efficiently translated into aberrantly truncated and potentially 
harmful proteins [20]. 
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Roquin is a RNA-binding protein, and it can interact with target mRNAs through its 
ROQ and CCCH-zinc finger domains, thereby regulating their stability and turnover.  
mRNA stability is regulated by the presence of specific sequences within the mRNA 
itself. Such regulatory elements are often located in the 3’UTR, as in the case of 
ICOS mRNA’s control by Roquin, but are also found in the coding sequence [27] or 
in the 5’UTR [28]. Well-known regulatory sequences are represented by the AU-rich 
elements (AREs), which are located in the 3’UTRs of various mRNAs [29]. ARE 
sequences are approximately 50 nt in length and contain several copies of an 
AUUUA pentamer. Three different ARE’s classes characterized by different 
deadenylation kinetics have been identified. Class II AREs contain 4 to 7 copies of 
the AUUUA pentamer within an U-rich context and are the most potent ones, 
compared to class I AREs (they contain only few pentamer elements) or class III 
AREs (they do not contain AUUUA sequences) [30]. ARE-induced mRNA 
degradation is mediated by both the exosome! [31], and in agreement with this model 
ARE binding proteins directly interact with subunits of the exosome, and the 
decapping-Xrn1 pathway [32]. Moreover, AREs can also mediate inhibition of 
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Exosome
A large complex of 3′→5′ 
exonucleases that functions in 
the nucleus and the cytoplasm 
in several different RNA-
processing and RNA-
degradation pathways.
Transcriptome 
The pool of mRNAs that is 
present in the cell under a 
given condition.
Deadenylase
An enzyme that removes the 
3′-poly(A) tail from RNA in a 
3′→5′ direction.
RNase D
Escherichia coli RNase D is a 
3′→5′ xoribonuclease that is 
required for processing of 
tRNA precursors. Many 
eukaryotic proteins with similar 
exoribonuclease domains have 
been identified.
The enzymes that perform each step in decay are 
outlined below and summarized in TABLE 1.
Deadenylation. As discussed above, deadenylation is 
the first step in bulk mRNA decay, although so far it 
remains unclear exactly how and when deadenylation 
is triggered. There are several characterized eukaryotic 
deadenylases, including PAN2–PAN3, CCR4–NOT and 
PARN (poly(A)-specific ribonuclease), each with unique 
properties.
PAN2–PAN3 is a PABP-dependent poly(A) nuclease 
that is involved in trimming the poly(A) tails of nascent 
mRNAs to the standard length of 60–80 nucleotides in 
S. cerevisiae9. Mammalian PAN2–PAN3 carries out 
the initial shortening of the tail of a β-globin reporter 
transcript from the usual 200 nucleotides to a length 
of ~80 nucleotides10. At this point, the deadenylation is 
handed over to another deadenylase, CCR4–NOT (see 
below). Whether PAN2–PAN3 has a role in deadenyl-
ating all mRNAs in higher eukaryotes is unclear — it 
seems likely that this function can be carried out by 
other deadenylases.
CCR4–NOT is the main deadenylase in S. cerevisiae11 
and is a large complex of nine proteins, two of which, 
Ccr4 and Caf1 (also known as Pop2), have exonuclease 
domains. In contrast to PAN2–PAN3, CCR4–NOT 
activity is inhibited by PABP12. In mammalian cells, 
CCR4–NOT has been shown to deadenylate reporter 
mRNAs10. CCR4 is a member of a large family of pro-
teins in higher eukaryotes, at least some of which are 
also deadenylases13.
PARN is unique in that it has cap-dependent dead-
enylase activity — that is, its processivity is enhanced 
by the presence of a 5′ cap on the mRNA14–16. Moreover, 
this deadenylase is inhibited by cap-binding proteins15,17. 
PARN has been implicated in the mass deadenylation of 
mater al mRNAs that occurs in Xenopus laevis oocytes 
during maturation18 and is also the main deadenylase 
activity in cytoplasmic extracts derived from various 
cell lines15,19,20. PARN is essential for embryogenesis 
in plants21,22, and is found in many higher eukaryotes 
including mammals and several insect species14,20, 
although there is no obvious counterpart in S. cerevisiae 
or Drosophila melanogaster23.
Interestingly, PAN2, CCR4, CAF1 and PARN all have 
ribonucleas  D-type (RNAse D-type), Mg2+-dependent, 
3′→5′-exonuclease domains, as does the nuclear exo-
some subunit RRP6 (also known as PM-Scl100)18,24, 
which is indicative of divergent evolution. Given 
that there are over a dozen candidate deadenylases in 
Figure 1 | Mechanisms of normal mRNA degradation. a | Most mRNAs undergo decay by the deadenylation-
dependent pathway. The poly(A) tail is removed by a deadenylase activity, shown here as either CCR4–NOT or PARN. 
Following deadenylation, two mechanisms can degrade the mRNA: either decapping followed by 5′→3′ decay or 3′→5′ 
decay. In the decapping pathway, the Lsm1–7 complex associates with the 3′ end of the mRNA transcript and induces 
decapping by the DCP1–DCP2 complex. This leaves the mRNA susceptible to decay by the 5′→3′ exoribonuclease XRN1. 
Alternatively, the deadenylated mRNA can be degraded in the 3′→5′ direction by the exosome, with the remaining cap 
structure being hydrolysed by the scavenger-decapping enzyme DcpS. b | In Saccharomyces cerevisiae, deadenylation-
independent pathways require recruitment of the decapping machinery. Here, Rps28B interacts with enhancer of 
decapping-3 (Edc3) to engage the decapping enzyme. Following decapping, the mRNA is degraded by Xrn1. 
c | Endonuclease-mediated mRNA decay initiates with internal cleavage of the mRNA, which generates two fragments 
each with one unprotected end. The fragments are degraded by XRN1 and the exosome.
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Figure 2: Different pathways of mRNA decay. ) Deadenylation-dependent mRNA decay. Removing 
of the poly(A) tail is mediated by CCR4-NOT or PARN complexes and is the rate limiting step of the 
pathway. Following deadenylation the targeted mRNA can be alternatively degraded by 3’ to 5’ 
exoribonucleases or by 5’ to 3’ exoribonucleases s Xrn1 followin  removal of the m7GpppN cap by 
the Lsm1-7 induced decapping enzymes Dcp1/Dcp2. b) Deadenylation-independent mRNA decay. 
In rare cases the decapping machinery can be recruited to the targeted mRNA without previous 
deadenylation by enhancers of decapping as Edc3. Rps28B directly interact with Edc3 to promote 
decapping of its own mRNA autoregulating its half-life. c) Endonucleas -mediated mRNA decay.
Endonucleases are enzymes that cut the mRNA internally, leading to formati n of two RNA 
frag ents, one of which lacks the poly(A) tail and is degraded by the exosome, while the other 
fr ment, since it lacks the m7GpppN cap, is degraded by Xrn1. The cartoon is taken from [4]. 
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translation of the target mRNA [33]. Further regulation of mRNA stability is achieved 
through modification of the ARE-binding proteins (ARE-BPs). p38 MAPK [34] and 
ERK [35] kinases have been shown to phosphorylate ARE-BPs modulating their 
ability to bind ARE sequences and to destabilize the target mRNA. Phosphorylation 
of HuR by protein kinase C (PKC), instead, shifts the cellular localization of HuR from 
the nucleus to the cytoplasm, where HuR can physically interact with its target 
mRNAs [36].  
mRNA stability and gene expression is regulated also by small noncoding RNA 
molecules with sequence complementarity with their target transcripts through the 
process of RNA interference (RNAi). Elements of the RNAi pathway that control 
mRNA turnover can be both short-interfering RNAs (siRNAs) or microRNAs 
(miRNAs). Ds-siRNA are ~ 21nt in length and are characterized by the presence of 
two nucleotides 3’ overhangs and phosphorylated 5’ ends [37]. One strand of the 
duplex is incorporated into the RNA induced silencing complex (RISC) and is loaded 
onto Argonaute (Ago) proteins, whereas the passenger strand behaves as a RISC 
substrate and is cleaved by the endonuclease activity of Ago2 [38]. The RISC-loaded 
guide strand drives the RISC to complementary target RNA molecules. In mammals, 
the endoribonuclease Ago2 cleaves the siRNA-targeted transcript and the generated 
fragments are removed from the cell by different cellular degradation pathways [39]. 
miRNAs, instead, are ~ 22nt RNA’s molecules which are characterized by partial 
complementarity with their target mRNAs. Approximately 25% of the human genes 
were estimated to contain miRNA-binding sites [40]. miRNAs are transcribed in the 
nucleus by the RNA polymerase II as larger polyadenylated and capped precursors, 
the pri-miRNAs [37]. These transcripts are processed by the RNase III enzyme 
Drosha to release a ~ 70nt long pre-miRNA precursor! [19]. The pre-miRNA is 
shuttled by the Exportin5-RanGTP complex from the nucleus to the cytoplasm [41], 
where a different RNase III enzyme, Dicer, releases a 22 nt long miRNA-miRNA 
duplex [42]. After unwinding of the transient duplex, one strand is loaded on the 
miRNA-associated multiprotein RNA induced silencing complex (miRISC) in 
association with the Ago proteins. The mechanism of post-transcriptional gene 
regulation by the RNAi pathway depends on the degree of complementarity of the 
miRNA’s seed region and its target. Imperfect complementarity is typical for miRNAs 
and leads to translational repression and shuttling of the repressed mRNA into P-
bodies, where it can be stored or degraded through mRNA-decay pathways![43] [44]. 
Ago and GW182 proteins, which are loaded on the miRISC, are major effectors of 
miRNA-mediated mRNA decay. The eukaryotic initiation factor 4G (eIF4G) binds to 
the poly(A)-binding protein PABPC1 leading to circularization of the mRNA to 
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increase translation efficiency [45]. GW182, by directly competing with eIF4G for 
binding to PABPC1, interferes with circularization of the transcript repressing 
translation and favouring the access of decapping and deadenylation machineries to 
their targets [46].  
1.3.2 Control of mRNA stability in the immune system 
Tight control of protein levels in the immune system is particularly important to allow 
efficient immune and inflammatory reactions. Post-transcriptional regulation of mRNA 
stability is widely used in the innate and adaptive immune systems to control the 
expression of many signaling and effector genes.  
ARE-mediated mRNA decay (AMD) in the immune system is particularly important to 
regulate the stability of mRNAs encoding for cytokines, chemokines and intercellular 
secreted factors [30]. Tristetraprolin (TTP) is a RNA-BP containing two CCCH-zinc 
finger domains which recognizes with high specificity ARE elements within 3’ UTRs 
of target genes [47]. TTP binds to AREs of several different genes, as TNF-α, CCL-2, 
CCL-3, GM-CSF, IL-2, IL-6 and INF-γ, inducing fast degradation of their mRNAs. 
TTP, by limiting the half-life of these cytokine transcripts, has mainly an anti-
inflammatory function in the immune system [30]. However, it has been shown that 
TTP can also act as pro-inflammatory molecule since it can target immune-
suppressive IL-10 mRNA for degradation in macrophages [48].  Furthermore, TTP 
targets the transcription factor E47, which regulates expression of the activation-
induced cytidine deaminase (AID). AID is critically involved in two central processes 
of the germinal center reaction, namely somatic hypermutation and class-switch 
recombination. Aged B cells are characterized by impaired class switch 
recombination and this process has been linked to the increased levels of TTP [34]. 
In rare cases ARE-containing mRNAs can be stabilized by ARE-BPs. The main 
example of stabilizing ARE-BPs is represented by HuR. IL-3 mRNA contains AREs 
elements which can be recognized by both HuR and TTP proteins, which compete 
for the same binding site on the target transcript [49].   
miRNAs have also a major role in the regulation of the immune system. miRNA-155 
is the best studied miRNA in the adaptive immune system. Several lymphocytes 
effector functions were shown to be regulated by miR-155. In TCR-stimulated naive 
T cell, miR-155 skews T helper (Th) cell differentiation towards a Th1 rather than a 
Th2 profile. Mir-155 contributes also in maintaining peripheral T cell tolerance by 
promoting survival and proliferation of regulatory T (Treg) cells (see chapter 2.1.3.2) 
Moreover, loss of miR-155 in mice has been shown to impair T-cell dependent 
antibody responses by regulating B cell secretion of TNF and lymphotoxin-α (LT-
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α)[50]. Finally, mir-155 regulates Pu.1, a transcription factor with different functions in 
B cells and dendritic cells (DCs). In B cells, miR-155 induced degradation of Pu.1 is 
important to promote class switching to IgG1! [51]. In DCs, instead, upregulation of 
miR-155 during the switch from antigen uptake to antigen presentation function in 
DCs is important to activate phagocytosis [52]. 
As previously anticipated, endonucleases have also been recently demonstrated to 
play important roles in the regulation of the immune system. The CCCH-zinc finger 
containing protein Zc3h12a binds to the 3’ UTR of IL-6 and through its 
endoribonuclease domain cleaves IL-6 mRNA. Additional targets of Zc3h12a as IL-
1b and IL-12b mRNAs have also been suggested [53].  
In general, control of the mRNA stability of genes involved in immune and 
inflammatory reactions is characterized by high degree of cooperativity, which 
probably increases the efficiency of the RNA degradation pathway. The same 
miRNAs, as mir-155, or the same ARE-BP, as TTP, can target and control the 
transcript stability of several different genes, as it has been previously described. 
Moreover, the highly unstable IL-6 mRNA represent a nice example of how a single 
mRNA molecule can be regulated in its stability through different mRNA decay 
pathways. In addition to the Zc3h12a binding site present in the 3’ UTR, IL-6 mRNA 
also contains an ARE [54] and a binding site for miR-26 [55].  Several different 
mRNA degradation pathways can then join the forces and cooperatively regulate the 
stability of single mRNA molecules tightly and efficiently controlling the final protein 
concentration.  
The process of mRNA degradation is highly compartmentalized and mainly takes 
place in the P-bodies. In conditions of cellular stresses, however, the SGs cooperate 
with PBs in regulating mRNA stability and turnover. Recently, it has been suggested 
that also the formation of SGs is highly important in the context of T lymphocyte 
biology. Even if transcription at a cytokine locus starts within a few hours after initial 
priming of naive T cells [56], secretion of effector cytokines is not abundant at this 
time and can be detected only after a second TCR stimulation. An interesting model 
that has been proposed to explain this phenomenon suggests that delayed cytokine 
secretion might be caused by the induction of an integrated stress response upon 
initial priming of the naive T cells, during which mRNAs coding for effector cytokines 
are stalled in translation and stored into SGs. In contrast, restimulation of the primed 
T cell through the TCR might release translation from the stress response leading to 
ribosomal mRNA loading and cytokine secretion [57].   
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2 Tolerance and Autoimmunity 
The immunological specificity of the B and the T cell receptors is the result of the 
process of somatic recombination of the immunoglobulin (Ig) locus in B lymphocytes 
or of the TCRβ and α loci in T lymphocytes. This process can generate millions of 
different TCRs and BCRs, and owing to its random nature also leads to the 
emergence of receptors that potentially recognize components of the same organism 
(= ”self”). The term tolerance summarizes a variety of processes that eliminate or 
neutralize such autoreactive lymphocytes. A breakdown of these mechanisms, which 
act on lymphocytes  both in primary (central tolerance) or secondary (peripheral 
tolerance) lymphoid organs, can lead to the development of autoimmune pathologies. 
2.1 T cell tolerance 
2.1.1  T cell development in the thymus 
T lymphocytes belong to the hematopoietic system, and derive from multipotent bone 
marrow precursors which enter the thymus, the non-self renewing hematopoietic 
organ where thymocytes are generated, at the cortico-medullary junction [58] . The 
thymus is subdivided into two different regions, an outer part, containing mainly 
immature thymocytes and called cortex, and an inner part, containing mature 
thymocytes and called medulla [59]. Once the progenitors have undergone 
commitment to the T cell lineage, they differentiate into double negative 1 (DN1) cells 
and progressively lose their potential for B [60] or NK cell differentiation [61]. The 
double negative stage (DN; CD4-CD8-) can be subdivided on the basis of CD25 and 
CD44 expression  into DN1 (CD25-CD44+), DN2 (CD25+CD44+), DN3 (CD25+CD44-) 
and DN4 (CD25-CD44-) [62]. Upon opening of the chromatin configuration of the T-
cell receptor β chain (Tcrb) locus and expression of recombination-activating genes 
(RAGs), which catalyze somatic rearrangements, cells at the DN2 or DN3 stages 
rearrange their Tcrb locus. The TCRβ locus contains numerous variable (Vβ), 
diversity (Dβ) and  joining (Jβ) regions as well as one constant (C) region. While the 
rearranged VDJ region of the TCR encodes for the antigen binding site of the 
receptor, the constant region encodes for the transmembrane domain and the short 
cytoplasmic tail of the TCR. A productively rearranged TCRβ chain pairs with the 
invariant pre-TCRα chain to form the pre-TCR which transduces a signal for further 
differentiation towards the DN4 and double positive (DP) stages [63]. Cells that do 
not produce rearrangements encoding a functional receptor die at the CD44-CD25+ 
stage of development during a process called β selection [64]! [65]! [66]. Pre-TCR 
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signaling induces allelic exclusion, a process that blocks recombination of the second 
TCRβ allele, ensuring that every cell expresses only a single TCRβ product [67]. 
During the transition from DN3 to DN4 the Tcrb locus becomes inaccessible and the 
cells undergo extensive proliferation during which RAG1 and RAG2 genes become 
inactive [1].   
 
 
  
Upon further thymocyte maturation, RAG genes are re-activated and the TCRα locus 
becomes accessible leading to the rearrangement of the α chain of the TCR (see 
Figure 3). In contrast to the TCRβ locus, TCRα lacks diversity genes, and it is 
composed only of Vα and Jα gene segments. The newly-formed TCRα chain pairs 
with the TCRβ chain to form the TCR. Allelic exclusion at the TCRα locus is less 
stringent than at the TCRβ locus. Indeed, cells that express on their surface a non-
functional TCR do not downregulate RAG genes as in the case of cells expressing a 
non-functional pre-TCR. This phenomenon allows the immature lymphocytes to 
undergo several rounds of rearrangements at the α locus to increase the probability 
to generate a functional TCR [68]. At this stage, the thymocytes also start to express 
the co-receptors CD4 and CD8 forming the double positive (DP) αβ-TCR-expressing 
immature cells, which represent about 90% of the lymphoid compartment in the 
thymus of young organisms.  
2.1.2  Central T cell tolerance 
One major mechanism of tolerance in T lymphocytes is represented by the deletion 
of autoreactive T lymphocytes in the thymus, a process which has been named 
central tolerance. More than 95% of thymocytes are lost during the stringent process 
of positive and negative selection that takes place in the thymus [69]. Approximately 
90% of DP thymocytes undergo death by neglect, a passive form of cell death 
caused by the failure of a αβTCR expressed by the thymocyte to engage a peptide-
MHC complex expressed on the cell surface of epithelial cells in the thymic cortex!
[70]. This process enriches the T cell compartment also for autoreactive cells, most 
Figure! 3:! T! cell!development!in!the!thymus,! showing!timing! of! Tcrb! and!Tcra! locus!rearrangement.!The! cortoon! is!taken!from!![1]!
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of which however are deleted through a process called negative selection that 
eliminates lymphocytes expressing a TCR which binds with very high affinity to a 
peptide-MHC complex. Two major mechanisms of negative selection have been 
described: 1) clonal deletion and 2) anergy.  
It has been proposed that  about 5% of thymocytes, corresponding to at least 50% of 
positively selected T cells, are removed by clonal deletion [59]. Positively selected T 
cells that can recognize with high affinity a ligand-MHC molecule complex undergo 
apoptosis (clonal deletion), while only DP tymocytes that express TCRs with low 
affinity for self-peptide-MHC ligands differentiate into CD4 or CD8 SP thymocytes 
(positive selection) and leave the thymus to populate the periphery. The effector 
pathways responsible for apoptosis during negative selection have not been fully 
understood yet. However, typical mediators of apoptosis in T lymphocytes in the 
periphery such as Fas [71] or caspase-1, 2, 3, 8, 9 and 11 [72] are, when deleted 
one-by-one, dispensable for deletion of self-reactive T lymphocytes. A different 
pathway which is known to control apoptosis depends on members of the BCL-2 
protein family. The BH3-only Bcl-2 family member Bim is required to instruct proper 
deletion of autoreactive lymphocytes in the thymus, and Bim-deficient animals [73] 
are characterized by impaired negative selection. The thymic medulla may be the 
predominant site where clonal deletion takes place because it is enriched with two 
different types of APCs, the dendritic cells (DC) [74] and the medullary epithelial cells 
(mTEC) [75], which are both important for the process of negative selection. 
Moreover mTECs are sites of promiscuous gene expression, i.e. they transcribe a 
large array of genes that are otherwise only expressed in distinct peripheral tissues 
[76]. The transcription factor AIRE (autoimmune regulator) is required for ectopic 
expression of peripheral antigens in mTECs, and if mutated leads to the 
development of the autoimmune polyendocrine syndrome type 1 in humans [77]. 
Mice deficient for AIRE develop an autoimmune syndrome similar to the human 
disease [78], confirming the importance of mTECs in negative selection. Clonal 
deletion, however, has been proposed to take place in the cortex as well. cTECs are 
non-professional APCs and do not express co-stimulatory molecules. It has been 
proposed that cTECs can present MHC-ligand peptides, but since they lack 
costimulation they can not efficiently induce apoptosis [79]. It has been instead 
suggested that cTECs mark a DP T lymphocyte in the cortex as self-reactive, and a 
subsequent stimulus from DCs induces efficient clonal deletion [80]. 
The second non-deletional mechanism of central tolerance is represented by 
induction of anergy, which is a state of unresponsiveness. Also in this case thymic 
epithelial cells that present MHC-ligand peptide can induce a state of 
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unresponsiveness in the immature T cells which are unable to respond to further 
stimulation [81].  
Although central tolerance is a highly efficient process, it cannot eliminate all the T 
cells which express an auto-reactive TCR on their surface. For this reason mature T 
cells leaving the thymus are controlled by peripheral tolerance mechanisms, and they 
induce lymphocytes at their first encounter with the self-antigen in the periphery to 
become tolerant. 
2.1.3  Peripheral T cell tolerance 
Healthy individuals are characterized by the presence of self-reactive thymocytes in 
the periphery. Since high affinity thymocytes are deleted in the thymus, most likely 
these autoreactive lymphocytes express a low-affinity TCR for self-antigens [82]. 
Outside the thymus self-reactive T lymphocytes are controlled through mechanisms 
of peripheral tolerance, which can be both T cells intrinsic, acting directly on the self-
reactive T cell like ignorance, anergy, phenotypic skewing or apoptosis, or T cell 
extrinsic, acting on the auto-reactive T cell via additional cells like regulatory T cells 
(Treg) or tolerogenic dendritic cells.  
2.1.3.1 T cell intrinsic mechanisms of peripheral T cell tolerance 
To achieve tolerance of autoreactive T lymphocytes in the periphery the simplest 
scenario is the ignorance of self antigens by the T cells. This is possible in two 
different ways. The first one is when the T cells and the respective auto-antigens are 
physically separated into two different compartments. This happens when the self 
antigens are sequestered into sites which are not easily accessible to the 
blood/lymph borne immune system [83]. A second way to induce tolerance by 
ignorance in the periphery is to prevent activation of a T cell in response to a 
stimulus which is too weak, for instance when the amount of antigen does not reach 
the threshold required to trigger a T cell response [84].  
As in the thymus, T cells can become anergic in the periphery as well, maintained in 
a state of reduced cellular proliferation and unable to produce cytokines in response 
to second stimulation. Anergy is induced by ligation of the TCR on the surface of 
mature T cells without costimulation [85] and at the same time signaling through 
alternative receptors as cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) [86] 
or programmed cell death 1 (PD-1) [87]. Signaling downstream of the TCR leads to 
calcium flux and NFAT nuclear translocation and activation. Both these events are 
required also for induction of anergy. In anergic cells, however, DNA binding by the 
activator binding protein 1 (AP1), a heterodimer composed of Fos and Jun, is 
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reduced, due to defective activation of the MAPK pathway [88]. Ras proteins, which 
belong to the superfamily of monomeric GTPases, are located on the inner surface of 
the plasmamembrane. Activation of the costimulatory pathway leads to the activation 
of guanine exchange factor (GEF) son of sevenless (SOS) which is linked to the 
receptor through the adaptor protein Grb2 [89]. Activation of SOS following CD28 
engagement leads to the exchange of GDP bound to the inactive form of Ras with 
GTP, inducing Ras activation and then efficient signaling through the MAPK pathway. 
In anergic cells, however, deregulation of MAPK activation is caused by a defect in 
the GTP loading of Ras. Defective MAPK activation and AP1 formation, together with 
intact NFAT nuclear translocation in anergic cells, leads for instance to impaired IL-2 
production, a hallmark of anergic T lymphocytes [90].  Moreover, the presence of 
NFAT in the cell nucleus of activated T lymphocytes without contribution from other 
MAPK-regulated transcription factors in anergic T cells, has been recently linked also 
to the ubiquitination pathway. Transcription of three E3 ubiquitin ligases, CBL-B, 
GRAIL and ITCH is induced in response to tolerogenic signals. Casitas B-lineage 
lymphoma (CBL-B) is activated by phosphorylation following TCR engagement and it 
can downmodulate peripheral T cell activation by regulating the Rho-family GEF 
Vav1 [91]. Mice lacking CBL-B develop autoimmunity with autoantibody production 
and resting T cells are hyperproliferative and secrete higher amounts of IL-2 in 
response to antigenic stimulation. Moreover, in cbl-b-/- mice proliferation and 
secretion of IL-2, as well as regulation of Vav1, are not dependent on CD28 
costimulation anymore [92].  
Even if a self-reactive T cell is fully activated tolerance can still be maintained if the 
immune response does not induce pathogenic effects. In this scenario autoimmune 
tissue damage is prevented by skewing the profile of the activated T cells towards a 
non pathogenic profile in terms of which cytokines and chemokine receptors they 
express. An important example is represented by CXCR5, a chemokine receptor that 
mediates migration of activated T cells to the B cell follicle. Optimal expression of 
CXCR5 by the T cells is achieved following activation of CD28 pathway, which is 
defective during presentation of self-peptides to T lymphocytes. Therefore 
tolerogenic signals can stimulate T cells to proliferate but migration to B cell areas of 
secondary lymphoid organs is impaired [93].  
The last mechanism of T cell intrinsic peripheral tolerance is represented by the 
activation induced cell death (AICD). Repetitive encounter of the mature T cell with 
self-proteins leads to activation of apoptotic mechanisms mainly through the 
activation of the Fas-FasL pathway. The importance of this mechanism in 
maintaining peripheral tolerance is revealed by the observations that defects in the 
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FasL pathway in humans cause the autoimmune lymphoproliferative syndrome 
(ALPS) [94], while in mice defects in Fas or FasL, respectively in MRL/lpr and gld 
mouse strains, lead to lymphoproliferative lupus-like syndromes [95].  
2.1.3.2 T cell extrinsic mechanisms of peripheral tolerance 
In the periphery DCs are the most important type of professional APCs and they 
mediate both immune responses and induction of tolerance. To achieve complete T 
cell activation the APC needs to transmit two different signals: 1) presenting peptide-
antigen on their MHC molecule to the TCR expressed on the T cell surface; 2) 
activation of dendritic cells leads to the expression of co-stimulatory molecules that 
engage CD28 on the T cells. Presentation of a self-peptide by an APC is not 
associated with activation of co-stimulatory pathways and in this case the APC 
transmits a tolerogenic signal. This phenomenon has been explained by two 
complementary models. The first model was proposed by Janeway [96] in 1992. His 
model suggests the presence of a distinctive recognition event involving the binding 
of conserved receptors on the APC’s surface to evolutionarily conserved pathogens 
components. Support to this theory came in 1997, with the discovery of the pattern-
recognition receptors (PRRs). Toll-like receptors (TLRs) are PRRs which can 
recognize pathogen associated molecular patterns (PAMPs) such as 
lipopolysaccharide (LPS), lipoproteins, peptidoglycans or DNA-containing 
unmethylated CpG motifs [97]. To date many different PRRs have been discovered, 
some of which are signaling PRRs as TLRs and CD14, which promote the ability of 
TLR4 to respond to LPS on the surface of macrophages, while others are secreted 
signaling PRRs found in plasma and tissue fluids as the mannose-binding lectin 
(MBL) which binds mannose-rich glycans on microbes in order to activate the lectin 
complement pathway. The third type of PRRs is represented by the endocytic PRRs 
like the mannose receptor, the scavenger receptor, the N-formyl Met receptor or the 
opsonin receptor which are expressed on the surface of phagocytes and promote the 
attachment of pathogens to these cells. The second model suggested was 
developed by Matzinger in 1994. This model proposes that the immune system does 
not discriminate between self and non-self, but the driving force of the immune 
system is the possible danger coming from invading pathogens [98]. The second 
signal necessary to activate the APCs in this view is represented by intracellular 
components of the attacked cells of the host which are representative of the damage. 
Molecules as heat shock proteins or mitochondrial components, which are released 
by necrotic cells but not by apoptotic cells which undergo normal turnover, can be 
Introduction !
! 17!
defined as damage associated molecular patterns (DAMPs) and as the PAMPs can 
instruct APCs to provide a full stimulus to T lymphocytes.   
The second mechanism of T cell extrinsic peripheral tolerance is represented by the 
presence of regulatory T cells (Treg) in the secondary lymphoid organs. Treg cells act 
in a dominant and trans-acting way and are characterized by suppressor activity 
which is induced upon TCR ligation, but once they are activated their suppressor 
function is completely unspecific [99]. Treg cells are constantly produced in the 
thymus [100] and they originate from thymocytes which express on their surface a 
TCR which bind self-peptides presented in the thymus with intermediate/high affinity 
[101]. It is not clear yet how a T lymphocyte bearing a TCR with intermediate/high 
affinity for self peptides is instructed towards negative selection in the thymus or 
towards a regulatory T cell fate [102]. The key transcription factor controlling Treg 
development is FoxP3 which is also the most reliable marker for the identification of 
Treg cells in humans and mice [103]. Mutations in the FoxP3 gene have been shown 
to cause the immune dysregulation, polyendocrynopathy, enteropathy, X-linked 
syndrome (IPEX). IPEX is an immunodeficiency syndrome that results in severe 
organ-specific autoimmune disease, confirming the important role that functional Treg 
cells play in maintaining immune homeostasis in the periphery preventing the 
development of autoimmunity [104]. 
2.2 B cell tolerance 
The development of B lymphocytes until the immature B cell stage takes place in the 
bone marrow. Immature or transitional B cells exit the bone marrow and migrate to 
secondary lymphoid organs such as the spleen, where they differentiate into mature 
peripheral B cells. B lymphocyte development is controlled through several 
checkpoints in both the primary and secondary organs. Breakdown of B cell 
tolerance is an important event in the development of autoimmune diseases.  
2.2.1  B cell development and tolerance in the bone marrow 
In mice B cell development takes place in the liver during fetal development and in 
the bone marrow after birth starting from hematopoietic precursors. According to the 
model established by the Weissman group long-term hematopoietic stem cells (LT-
HSC) develop into short-lived hematopoietic stem cells (SL-HSC) and further into 
multipotent progenitors (MPP). MPPs, which have lost self-renewing potential, can 
differentiate into both common myeloid precursors (CMP) or common lymphoid 
precursors (CLP), the latter giving rise to T, B, NK and dendritic cells [105]. 
Commitment of the precursors to the B cell lineage is dependent on the transcription 
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factor Pax5, which instructs the B lineage and suppresses alternative lineage choices 
[106]. The first B lineage restricted cells are found in the pro-B cell stage. Upon 
expression of the RAG genes recombination of the immunoglobulin heavy chain 
(IgH) locus takes place, starting with the joining of one DH and one JH gene and 
concluding with the joining of a VH segment to the preformed DHJH complex [107]. 
The VHDHJH-encoded µ chain protein associates with the surrogate light chain (SLC) 
composed of λ5 and VpreB to form the pre-BCR [108]. At the pro-B cells stage also 
the Igα/Igβ molecules start to be expressed in a complex with the chaperone 
molecule calnexin. The presence of the Igα/Igβ signaling molecules is indispensable 
for further differentiation of B cells, since the developmental block at the pro-B cells 
stage seen in RAG-/- mice can be overcome by treatment of the mice with an α-Igβ 
mAb [109]. The first checkpoint of B cell development takes place at the pre-B cell 
stage. It has been postulated that only µ chains which can associate with the SLC to 
form a functional pre-BCR can promote cell proliferation and progression to later 
stages of development [110]. Signaling through the pre-BCR leads also subsequently 
to downregulation of the SLC and the RAG genes, limiting proliferation of the B cell 
clones and preventing recombination of the second allele of the Igh locus (allelic 
exclusion) [111]. The pre-BCR might also play a role in negative selection, since 
mice lacking the SLC develop higher titers of anti-nuclear DNA antibodies [112]. 
Small post-mitotic pre-B cells rearrange their light chain loci upon expression of a 
functional pre-BCR [113]. V to J recombination leads to expression of a κ or λ chain 
which pairs with the preformed µ chain. Expression of a functional light and heavy 
chain complex (IgM) on the surface of the cell is a feature of immature B 
lymphocytes (see Figure 4).  
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Immature B cells undergo selection prior to be exported in the periphery. From the 
immature B cell stage onwards, the process of clonal selection is Ag-dependent. 
Negative selection of self-reactive B lymphocytes is mediated by two different 
mechanisms: clonal deletion [114] and receptor editing [115]. It has been proposed 
that the site of first encounter of the antigen defines which mechanism of negative 
tolerance is utilized. In the bone marrow, autoreactive immature B cells undergo BCR 
editing, because of signals delivered by the microenvironment that block apoptosis 
favour RAG re-expression [116]. BCR editing involves secondary Ig genes 
rearrangements to develop a new BCR which is not reactive to self-peptides. 
Receptor editing takes place mainly at the light chain locus, leading to expression of 
a new light chain which might change specificity of the BCR [117]. Clonal deletion 
instead functions predominantly in bone marrow immature B lymphocytes that 
exhausted their editing potential [118]. Immature B cells in the periphery, instead, 
lack the signals from the bone marrow and the main mechanism of negative 
selection is therefore apoptosis as result of BCR engagement [116].  
Figure 4: B cell development in the bone marrow and in the periphery. Committed pro-B cells, upon 
expression of the RAG machinery, rearrange the IgH locus, leading to production a µ chain which, if 
able to pair with the SLC, forms the pre-BCR on the surface of the pre-B cells. At this stage both 
negative and positive selection takes place. Upon productive rearrangement of the light chain locus 
the pre-B cells progress to the stage of Immature B cells, which express on the surface a complex of 
light and havy chains, the IgM. Immature B cells leaving the bone marrow enter the periphery and 
become Transitional B cells. Expression of different markers on the surface of different transitional B 
cell subtypes in the periphery is shown. Cartoon from [3]. 
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2.2.2  B cell maturation and peripheral B cell tolerance 
2.2.2.1 B cell maturation 
Immature B cells that survive negative selection in the bone marrow are released into 
the periphery where they differentiate into transitional B cells. Transitional B cells are 
characterized by high expression of IgM and CD24 and three different subtypes have 
been described: T1 (which express no or low levels of L-selectin, IgM, CD23 and 
CD21), T2 (which express high levels of L-selectin, IgM, CD23 and CD21) and T3 
(which differ from T2 by lower expression of IgM on the surface) (Figure 4).  
A small fraction of transitional cells differentiate towards mature peripheral follicular 
(FO) and marginal zone (MZ) B cells. A complex network of interactions between 
BCR- and nonBCR-mediated signaling pathways dictate the fate of the transitional B 
lymphocytes. Using a monoclonal BCR mouse line specific for the self-peptide 
Thy1/CD90 it has been demonstrated that BCR-crosslinking by low doses of self-
antigen induces cell survival of immature transitional B lymphocytes [119], indicating 
that positive selection happens in the periphery as well. Together with a previous 
publication, [120], this study provides support to a model according to which 
increasing the strength of the stimulation through the BCR leads to differentiation of 
the transitional B cells towards MZ (intermediate BCR signal) rather than FO B cells 
(weak BCR signal). Other signals, however, participate, together with BCR 
engagement, in the decision between survival or death of the transitional B cells. The 
tumor necrosis factor family member B cell activation factor (BAFF) has major effects 
on B cell development. It is secreted by radioresistant stromal cells and myeloid cells. 
Binding of BAFF to BAFF-R, one of its three receptors, ensures the survival of 
transitional B cells and allows them to differentiate to FO and MZ B cells. Signaling 
through the other two BAFF receptors TACI and BCMA is dispensable for this 
purpose [121]. Several transcription factors control B cell development and tolerance 
in the periphery. The transcription factor family NF-κB is activated by both BCR 
engagement, through its canonical pathway, and BAFF-R signaling, through its 
alternative pathway. BCR engagement is linked to the activation of the canonical NF-
κB pathway through the trimolecular complex CARMA1-Bcl10-MALT1 [122]. Mice 
lacking CARMA1 [123], Bcl10 [124] and MALT1 [125] are characterized by reduced 
numbers of MZ B cell, while the FO subset was minimally affected. Establishment of 
the FO compartment, however, is still highly dependent on the activation of the 
canonical NF-κB pathway, since loss of Nemo, master regulator of canonical NF-κB 
activation downstream of CARMA1-Bcl10-MALT1, in developing B cells leads to 
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defective differentiation of MZ and FO B cells [126]. Blockade of the alternative NF-
κB pathway also leads to reduced numbers of peripheral mature B lymphocytes, as 
assessed in irradiated chimeras reconstituted with IkB Kinase-1/α-/- fetal liver cells 
[127]. BAFF-/- and BAFF-R-/- animals, however, show a more pronounced loss of 
peripheral mature B cells compared to the reconstituted IKK1-/- chimeras, indicating 
an NF-κB independent mechanism of action by BAFF signaling.  
2.2.2.2 Peripheral mechanisms of B cell tolerance 
Despite the control checkpoints in the bone marrow, some autoreactive B cell clones 
can escape central tolerance and migrate to the secondary lymphoid organs. In the 
periphery, however, several mechanisms prevent these cells to become pathogenic. 
For a few days after release from the bone marrow, these immature-transitional B 
lymphocytes, unlike mature B cells, are sensitive to BCR-induced apoptosis or to 
anergy, a state of unresponsiveness during which the cells lose the ability to be 
activated by antigenic stimulation. In this way autoreactive B cells that escape central 
negative selection can be deleted in the periphery upon encounter with the self-
antigen [128]. Therefore, upon BCR crosslinking, immature and mature B cells 
respond in different ways. While in vitro sIgM stimulation of immature B lymphocytes 
results in cell death, the same stimulus applied to mature B cells leads to activation 
and proliferation [129]. The process of maturation of the transitional B cells causes 
changes in the properties of the cells to allow different responses to BCR 
engagement. Upon cross-linking in mature B cells, for instance, the BCR immediately 
translocates into lipid drafts and it is rapidly internalized into the cell, while in 
immature B cells BCR’s compartmentalization into lipid drafts is impaired [130] due to 
lower membrane’s levels of unestherified cholesterol [131].  
A different mechanism of peripheral tolerance at later stages of B cell maturation is 
represented by downmodulation of BCR signaling through expression of inhibitory 
co-receptors such as CD32 (FcγRIIb) [132]. Activatory signals delivered through the 
BCR are usually counterbalanced by simultaneous cross-linking of the FcγRIIb 
receptor on GC B cells. In this way, only B cells with sufficient affinity for the antigen 
can overcome the inhibitory block mediated by FcγRIIb [133]. Exclusion of self-
reactive clones from GCs was also shown to prevent development of autoimmune 
pathologies in humans [134]. Despite the self-reactive VH4-34 B cell clone being 
positively selected and well represented in the naive pool of B lymphocytes, it is 
excluded from the germinal centers and prevented from differentiating towards 
antibody-producing plasma cells. Moreover, full activation of B cells during T-cell 
Introduction !
! 22!
dependent processes can be achieved only in the presence of co-stimulation by T 
lymphocytes through CD40 engagement and cytokines, preventing the activation of 
B cells upon self-antigen presentation (see chapter 3.2). 
As described in chapter 2.2.2.1, survival of mature B cells depends on signals 
transmitted through BAFF-R. Competition for BAFF limits B cell numbers and 
represent an other important checkpoint during B cell maturation.  
3 Antibody- and cell-mediated immunity 
The term “immune system” describes a diverse group of mechanisms which have 
evolved to protect the organisms from invading pathogens. The most primitive 
immune system is the innate immune system. Its mechanism of protection relies on 
the expression of germline encoded receptors which can recognize conserved 
patterns on different classes of pathogens and which can trigger an inflammatory 
response.  Only later during evolution the adaptive immune system has evolved. In 
contrast to innate immunity, adaptive immunity relies on cells which can diversify 
their receptors through somatic recombination in order to specifically respond to 
pathogen-derived antigens. Generation of a vast repertoire of cells which can clonally 
expand and differentiate upon activation is than essential for the generation of an 
efficient adaptive immune system.  
3.1 Mature B cell differentiation 
Stimulation of a mature B cell leads to activation, proliferation and differentiation 
rather than anergy or apoptosis as seen in immature B cells (see chapter 2.2.2.2). 
However, proliferation and activation of naive B cells is dependent on the presence 
of helper T (TH) cells, their cytokines or other activation signals like TLR-ligands [135]. 
Depending on the nature of these signals, a mature B cell can enter three different 
developmental pathways after activation, it can become a short-lived antibody-
secreting plasma cell, a memory B cell, or it can enter a germinal center reaction.   
Upon immunization of mice with a thymus-dependent (TD) antigen, two different 
populations of B cells originating from the same original clone are observed in the 
spleen: the extrafollicular and the germinal center B cell population [136]. When 
recirculating B cells in the blood recognize an antigen [137], they migrate to the T-
cell-rich zone in the secondary lymphoid organs following upregulation of CCR7, the 
receptor for the T-zone chemokines CCL19 and CCL21 [138]. Extrafollicular plasma 
cells develop after migration of the activated clones to the extrafollicular areas at the 
junction between red pulp and T-cell zone. In the T-cell zone primed T cells interact 
with antigen-stimulated B cells resulting in cell cycle entry and plasma cell 
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commitment induced by upregulation of the transcription factor B lymphocyte induced 
maturation protein-1 (Blimp-1) [139]. These plasma cells produce an early wave of 
low affinity antibodies. Most of them are short-lived and die by apoptosis [140], but a 
small percentage can compete to enter into long-lived niches [141].  During an 
extrafollicular antibody response B cells do not undergo somatic hypermutation. 
Other B blasts can remain in the follicles and enter the germinal center reaction 
undergoing affinity maturation (see chapter 3.2). It is not completely clear yet why 
some B cells enter the GC reaction while others enter the plasma cells development 
pathway directly. It has been proposed that the strength of BCR engagement 
determines the fate of the B cells, with high affinity B cells preferentially enrolled into 
the extrafollicular plasma cell developmental pathway [142]. The third pathway of 
differentiation of mature B cells leads to formation of low-affinity memory B cells. 
Most of the memory B cells in mice derive from germinal center reactions and have 
been shown to be somatically hypermutated. However, unmutated memory B cells 
have been detected in Bcl6-/- mice, which can not develop GC, confirming that 
memory B cells can be generated independently of somatic hypermutation and GC 
formation [143].  
3.2 The Germinal Center reaction 
The germinal centers are dynamic structures which develop in secondary lymphoid 
organs of birds and mammals during an immune response to infectious organisms. 
During the germinal center reaction activated B cells can mutate their BCR specificity 
and undergo affinity maturation, which leads to production of high-affinity antibodies 
and long-lived memory B cells. GCs are characteristic of TD immune responses, but 
they can also be generated in a thymus-independent (TI) manner in response to 
some TI antigens like the bacterial polysaccharide α(1-6)dextran [144] [145], even if 
in this case the efficiency of the reaction is reduced.  
Activated B cells that mature into GC-precursors migrate to the primary follicle, 
where the B cells start to proliferate forming a GC. The structure of the germinal 
centers has been subdivided by histological examination into the dark zone, which 
mostly consists of highly proliferating centroblasts, and the light zone, in which non-
dividing centrocytes are situated within a mesh of follicular dendritic cells (FDCs), T 
cells and macrophages [146].  
Germinal centers B cells can be detected 4-5 days after immunization [136]. 
Proliferating centroblasts in the dark zone downregulate surface expression of Ig and 
start somatic hypermutation (SHM) upon activation of the activation-induced cytidine 
deaminase (AID) [147]. The process of SHM modifies the variable region of BCR by 
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introducing single nucleotide substitutions, small deletions or duplications into the 
rearranged sequence [148]. After the process of SHM the cells (centrocytes) stop to 
divide and re-express the hypermutated receptor.  
Migration of the B cells between the dark and the light zone in the GCs is mediated 
by chemokine gradients generated by the stromal cells. Centroblasts are 
characterized by high expression of CXCR4 and migrate towards the CXCL12 
chemokine highly expressed in the dark zone, while CXCR5 directs the cells towards 
the light zone abundant for CXCL13 [149].  
A stringent process of selection rescues high-affinity B cells from apoptosis during 
which a specific subset of Th cells called follicular helper T (TFH) cells play a critical 
role [150]. GC B cells are naturally prone to undergo apoptosis and it has been 
shown that they lack anti-apoptotic factors as Bcl-2 and its family members, while 
they are rich in pro-apoptotic molecules [151]. B cells in which mutations in the newly 
formed immunoglobulin lead to production of non-functional or non-binding 
antibodies undergo rapid cell death because of the pro-apoptotic program of the GC 
B cells. TFH cells represent then a critical checkpoint to maintain tolerance in the 
germinal centers.  
Differentiation of CD4+ T cells into the TFH subset has been shown to require strong 
or prolonged signals through the TCR [152]. Upon expression of the CXCR5 receptor 
and migration into the CXCL-13-rich B cell follicles [153], TFH cells can provide 
instructive signals for B cell differentiation [154]. Survival signals transmitted by the 
activated TFH cells comprise both activation of costimulatory pathways and cytokine 
secretion. Transient expression of CD40L (CD154) on the surface of activated CD4 T 
cells, which can interact with constitutively expressed CD40 on the B cell surface, 
has been shown to transmit a crucial survival signal to B cells, since mice lacking 
CD40 or CD40L can not mount normal germinal center reactions [155]. Moreover, 
signaling through CD40 stimulates B cell proliferation and facilitates cytokine-induced 
class switching [156]. The inducible T cell costimulator (ICOS) is also expressed at 
high levels on activated TFH cells [157] upon activation of the CD28 pathway [158]. 
ICOS ligand (ICOSL) instead, is constitutively expressed on B cells, and ICOS-
ICOSL engagement provides critical signals to TFH cells required for initiation and 
maintenance of GC reactions [159]. Complete activation of TFH cells induces 
production of specific cytokines, which control B cell survival, proliferation and Ig 
class switch recombination (CSR). IL-21 production enforces the generation of TFH 
cells upon binding to the IL-21R expressed on T cells, but it also promotes 
differentiation of centrocytes by binding to IL-21R on B cells in the GC [160]. Plasma 
cell differentiation was indeed impaired in IL-21-/- and IL-21R-/- mice, and Ig V gene 
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mutation and selection were attenuated [161]. Moreover, B cell proliferation was also 
diminished during the late GC response in these mice. TFH cells have also been 
shown to secrete the cytokine IL-4 in response to Th2 polarizing pathogens and in 
these conditions, IL-4 secretion is critical to induce B cell maturation and expansion 
[162].  
Upon BCR stimulation and activation of co-stimulatory signals, high affinity 
centrocytes are selected and rescued from cell death. In the light zone of the 
germinal centers, selected centrocytes undergo the process of CSR, by which B cells 
switch their Ig class expression from IgM or IgD to other classes with different 
effector functions.  
Terminal differentiation of B cells as a result of the GC reactions leads to 
development of high-affinity plasma cells and memory B cells. However, the signals 
that induce B cells to become a plasma cell or a memory B cell are still largely 
unknown, even if there are some indications that expression of a high affinity BCR 
skews B cells differentiation towards plasma cells [163]. The regulation of several 
transcription factors have been shown to be crucial to allow plasma cell 
differentiation. Loss of Pax-5 represent the first-step towards formation of plasma 
cells [164], while downregulation of Bcl-6 releases the repression of Blimp-1 allowing 
plasma cell differentiation [165].  
Together with the previously described tolerance checkpoints (see chapter 2), further 
tolerance mechanisms also control the accumulation and function of TFH cells in the 
GC reaction. The lifespan of TFH cells is tightly controlled. TFH cells express higher 
levels of Fas on their surface, and are more sensitive to cell death after TCR 
stimulation compared to naive or memory helper T cells [166]. Accumulation of TFH 
cells in sanroque mice plays also an important role in the development of the 
autoimmune phenotype, since sanroque mice deficient for SAP can not accumulate 
TFH cells nor form GCs and they are protected from the lupus-like disease [9] (see 
chapter 1.2). Treg cells in the GC reactions can also suppress TFH function limiting 
provision of help to B lymphocytes [167]. Maintaining normal numbers and function of 
TFH cells in the GC reaction is then fundamental to enable TFH cell-mediated selection 
of high affinity GC B cells which are non-self reactive.  
3.3 Cell-mediated responses 
Immunity to intracellular pathogens relies on induction of specific cell-mediated rather 
than antibody-mediated immunity. The main effectors against pathogens located in 
the cytoplasm of host cells are the CD8+ cytotoxic T lymphocytes (CTL). Their 
activation requires presentation of antigens in association with MHC class I (MHCI) 
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molecules on the surface of APCs in association with co-stimulatory and cytokine 
signals [168]. Upon activation of the CD8 T cell, an initial phase of expansion and 
acquisition of effector functions, such as cytotoxicity and cytokine secretion, is 
followed by a contraction phase during which the majority of reactive T cells 
undergoes apoptosis and the memory compartment is generated. The exact 
mechanism of differentiation from naive to effector and memory CD8 T cells has not 
been identified yet, but several models have been proposed (see Figure 5). The 
uniform potential model proposes that memory CD8 T cells arise directly from 
effector T cells. Support to this theory comes from the observation that memory T 
cells derive from cells that previously displayed effector functions as Granzyme B 
promoter activity [169]. Moreover, precursors of the memory T cell compartment, 
characterized by high expression of IL7Rα, have been identified within the effector 
CD8 T cells [170]. Memory T cells, however, display many characteristics typical of 
naive rather than effector T cells. Alternative models have been proposed to explain 
this discrepancy. The straight to memory differentiation model proposes that naive T 
cells can directly differentiate towards memory cells. In this scenario cytokines play 
an important role, since it has been shown that the presence of inflammatory 
cytokines (as IL-12) [171], INF-type-I [172] and IL-21 [173] favours differentiation 
towards effector cells, while antigen/costimulation alone leads to memory T cell 
formation [174]. The third proposed model of CD8 T cell differentiation is named 
decreasing potential model. According to this model, effector T cells progressively 
loose their memory potential during the immune response and are pushed towards 
terminal effector cell differentiation [175].  
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On the basis of cell surface protein expression and proliferative capacity, two 
different subsets of effector CD8 T cells have been described. Short-lived effector 
cells (SLECs) are identified as CD8+CD44hiKLRG1hiIL7Rαlo cells and are 
characterized by direct cytotoxic activity but low proliferative potential. Memory 
precursors effector cells (MPECs), instead, are recognized as 
CD8+CD44hiKLRG1loIL7Rαhi cells and can give rise to long-lived memory cells [176]. 
MPECs represent the precursors of two different CD8 memory cells, the T-central-
memory (TCM) and the T-effector-memory (TEM) cells [170]. TCM cells are found 
predominantly in lymph nodes, and accordingly they express high levels of the lymph 
node homing receptor CD62L. TCM cells represent the cells with the highest 
proliferative capacity upon re-encounter with the antigen and they rapidly develop an 
effector phenotype, but they have reduced cytotoxicity. TEM cells, instead, do not 
express CD62L and are mostly found in non-lymphoid tissues where they can 
survive for long periods [177]. Moreover, TEM cells are characterized by pronounced 
cytolytic potential and can rapidly secrete high amounts of cytokines upon re-
stimulation [178] and can rapidly control invading pathogen at the site of their entry 
into the organism.  
Upon encounter with an antigen, naive CD8 T cells clonally expand and differentiate 
towards CTLs. The effector functions of these cells comprise both cytolysis of the 
infected cells, and production of cytokines, chemokines or microbicidal molecules. 
Cytolysis of infected cells can be mediated by two different pathways. The first one is 
lymphocytes that reside in the gut, lung-airways or brain
retain CD69 expression [48!!,49]. Similarly, existence of
developmental and functional subdivision of MBCs (e.g.
pre-plasma MBCs) is also becoming apparent [10]. Such
functional, anatomic and phenotypic heterogeneity in the
CD8 T-cell memory pool has important consequences for
immunity, and the factors that govern this cell fate
decision are of major interest.
Memory CD8 T-cell differentiation
Although it is well-established that effector plasma cells
and MBCs differentiate along separate pathways, the
lineage of memory T-cell development is not fully under-
stood. The conventional model of memory CD8 T-cell
differentiation is the linear differentiation model
(Figure 2) [32], which proposes that memory cells are
derived directly from effector cells. The use of CRE/
258 Lymphocyte activation
Figure 2
Models of memory cell differentiation. A simplistic rendering of the currently popular models of B-cell and T-cell differentiation are presented. (a) The
first model represents the B-cell paradigm of divergent pathways traced by effector and memory cells. T-cell differentiation into effector and memory
cells might also be driven along these divergent pathways, depending on antigen (Ag) dose or inflammatory stimuli. (b) The second model is a
representation of the more conventional linear pathway of differentiation of naı¨ve T cells into effector cells and ultimately into memory cells. (c) The
third model is a variation of the linear differentiation theme that allows effector cells that die to be distinguished from those that survive and differentiate
into long-lived memory T cells. It is based on the decreasing potential hypothesis, which states that the duration and level of antigenic stimulation
largely govern the effector and memory T-cell balance.
Current Opinion in Immunology 2006, 18:255–264 www.sciencedirect.com
Figure 5: three different models of CD8 T cell 
differentiation have been proposed. a) Straight-to-
memory model: cytokines as IL-12 and IL-21 or 
type I INF play an important role in determining 
the fate of a naive T cell activated through 
antigen+co-stimulation. b) Uniform potential 
model: memory T cells derive directly from effector 
T cells during the contraction phase of the 
response. c) Decreasing potential model: 
activated T cells progressively loose their ability to 
differentiate towards memory T cells. Duration and 
level of antigen stimulation largely determin the 
effector/memory ratio. 
Cartoon from [2] 
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the granule exocytosis pathway and it depends on the pore-forming molecule 
perforin and granzymes. Stimulation of the CTL leads to activation of a Ca++-
dependent degranulation process which releases perforin and granzymes from 
intracellular granules into the localized space between the CTL and the target cell 
[179]. Secreted perforin and granzyme B have complementary roles in inducing lysis 
of a target cell, since perforin lysis the target cells, while granzyme B fragmentizes 
the DNA [180]. The second cytolytic mechanism of CTLs depends on upregulation of 
FasL on the lymphocyte surface which can initiate programmed-cell death upon 
ligation of Fas (CD95) on target cells [181]. Activated CD8 T cells, however, can also 
secrete cytokines such as TNFα, and chemokines, which recruit effector cells as 
neutrophils or macrophages to the site of infection [182]. Moreover, the calcium influx 
induced by TCR stimulation induces NFAT1 protein which transactivates INFγ gene 
promoter leading to secretion of INFγ by effector CD8 T cells [183]. 
4 Systemic lupus erythematosus 
4.1 Systemic lupus erythematosus in general 
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the 
presence of autoantibodies due to breakdown of tolerance affecting multiple organs, 
including the skin, hematopoietic and lymphoreticular organs, joints, kidney, lung and 
cardiovascular structures. The incidence of SLE in Northern Europe is around 40 
cases every 100,000 persons and up to 200 cases per 100,000 persons among 
blacks [184]. 90% of patients with lupus are females; during the reproductive years 
the ratio of diagnosis between females and males is 10 : 1, suggesting a potential 
pathogenic role of female hormones [185].  
The disease is characterized by chronic inflammation in different organs and by the 
production of autoantibodies directed against intracellular components. Several 
different autoepitopes in humans have been identified: double stranded DNA 
(dsDNA), nucleosomes, Ro (ribonucleoprotein complex), La (RNA-binding protein), 
phospholipids, C1q (subunit of the C1 complement) and alpha-actinin (cytoskeleton 
component) [186] [185]. Anti-dsDNA antibodies are highly specific for lupus, and, 
even if they are probably not the main source of kidney damage, they have been 
associated with lupus nephritis. Two different theories have been proposed to explain 
their role in the development of tissue damage. The first one proposes that anti-
dsDNA antibodies can bind to nucleosomes in the bloodstream and then deposit as 
complexes in the renal glomerular basement membrane where they activate the 
complement leading to glomerulonephritis [187]. The second model posits that anti-
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dsDNA antibodies are characterized by high polyreactivity and have a pathogenic 
role in the kidney by reacting with renal proteins. Kidney pathology, however, has 
also been linked to the presence of autoantibodies against anti-α-actinin, a protein 
which cross-links actin and which is critical to maintain proper functionality of 
podocytes, components of the glomerular filtration barrier [185]. 
Different pathways have been shown to be affected in lupus, and altered functionality 
of both T and B lymphocytes has been described. In general, T lymphocytes provide 
excessive help to B cells and are characterized by impaired production of IL-2. 
Indeed, in T cells isolated from lupus patients stimulation of the TCR induces an 
early and enhanced signaling response characterized by increased calcium flux and 
cytosolic protein tyrosine phosphorylation caused by the decreased expression of 
CD3ζ and its replacement by FcRγ [188]. This effect has been explained by 
decreased levels of Elf-1 in SLE T cells. The transcription factor Elf-1, indeed, can 
bind to the promoter regions of both CD3ζ and FcRγ genes, enhancing the activity of 
the first promoter, and repressing the activity of the second [189]. Moreover, T cells 
from the lupus prone MRL/lpr mouse display aggregated lipid raft containing high 
concentrations of signaling molecules, which can enhance T cell activation, and the 
number of lipid raft-containing T cells increases with age and disease development 
[190]. As described in chapter 2.1.3.1, also the transcription factor NFAT is important 
in maintaining peripheral T cell tolerance. Indeed, upregulation of NFAT in T cells 
from lupus patients causes increased expression of the co-stimulatory molecule 
CD40L, but it fails to upregulate IL-2 because of decreased AP1 levels in SLE T cells 
[191]. Together with enhanced T cell activation, lupus patients display aberrant 
cytokine production. In particular, the defective IL-2 production is responsible for 
impaired Treg cell function [192] and decreased AICD [188]. IL-17, which can amplify 
an inflammatory response by recruiting effector cells, is instead increased in sera of 
patients with lupus and its levels correlate with disease severity. IL-17 acts in 
synergy with BAFF to promote survival and proliferation of B cells, GC formation and 
differentiation towards Ig-secreting cells [193]. 
The B cell compartment of lupus patients shows evidence for violation of several B 
cell tolerance checkpoints. In general, SLE B cells are hyperactive, and BCR 
stimulation induces higher calcium flux and protein tyrosine phosphorylation [194]. As 
previously described, inhibitory co-receptors modulate the threshold of activation of B 
lymphocytes. Decreased expression of the inhibitory co-receptor FcγRIIb on memory 
B cells of lupus patients [195] or decreased Lyn levels [196], a protein tyrosine 
kinase which mediates FcγRIIb signaling, might account for increased BCR signaling. 
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In mice, overexpression of the CD19 co-receptor has also been associated with 
increased autoantibodies production and breakdown of peripheral tolerance by 
increasing BCR signaling [197]. Together with altered B cell activation threshold, the 
second common defect within the SLE B cell compartment is represented by an 
increased cell survival. In mice many defects have been shown to increase B cell 
longevity. Enforced Bcl-2 expression [198] leads to survival of autoreactive B cell 
clones which are usually deleted by negative selection and to development of a 
lupus-like syndrome in mice. In humans, the Bcl-2 family member Bfl-1 has been 
shown to be upregulated in SLE B cells [199]. B cell extrinsic signals can also allow 
autoreactive B cells to escape negative selection. As seen in chapter 2.2.2.1, BAFF 
is a potent costimulator of B cell survival when coupled with BCR ligation in the 
periphery. Indeed, transgenic mice overexpressing BAFF were shown to develop 
autoimmune disorders [200] and elevated serum levels of BAFF have been reported 
for lupus patients [201]. Moreover, constitutive activation of the canonical NF-κB 
pathway can replace BAFF-R signaling in B cells and increase survival of potentially 
autoreactive transitional B cells in mice [126].  
4.2 The etiology of Systemic Lupus Erythematosus 
The etiology of SLE is mostly unknown, but probably both genetic and environmental 
factors play an important role in the development of the disease.  
Environmental factors which have been shown to favor development of SLE include 
drugs such as procainamide, hydralazine and quinidine (drug-induced lupus) or viral 
infections. In particular, Epstein Barr Virus (EBV) infection has been linked to SLE 
through serological and DNA studies. Infection with EBV leads to production of 
antibodies against the viral protein EBNA-1, which, through a process of molecular 
mimicry, cross-reacts with lupus-associated self antigens [202]. Moreover, through 
the process of epitope spreading, the cross-reactive autoantibodies can target 
additional, non-cross-reactive autoepitopes, leading to production of different, 
pathogenic autoantibodies.  
In both humans and mice several genetic loci have been linked to SLE. Genetic 
contribution is an important factor in development of SLE. However, genetic factors 
might not be sufficient to cause the disease. Indeed, it has been shown that 
monozygotic twins have a concordance rate for lupus of ∼ 25%, while it decreases at 
∼ 2% among dizygotic twins [185]. One of the most important and best well studied 
ones is present at the cytogenetic location 1q23. Within this locus the Fcγ receptors 
cluster together. They function to clear IgG antibodies and immune complexes from 
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the circulation and, since renal disease in SLE patients is often caused by immune 
complex deposition, they have been considered target genes since long time [203]. 
The HLA (human leukocyte antigen) region has also been described as susceptibility 
region for SLE when specific haplotypes spanning the MHC class II region are 
present [204]. Loss of one allele of three different components of the early classical 
complement pathway, C1q, C2 and C4 can also predispose to development of lupus 
[205]. Deficiency of complement components might lead to less efficient removal of 
apoptotic debris by phagocytes increasing the source of autoantigens which are 
usually confined inside the cells [206]. Recently, polymorphisms within the TNFAIP3 
genomic locus, encoding for the NF-κB inhibitory protein A20, have been associated 
with autoimmune disorders, including SLE. Most of the disease associated 
polymorphisms have been mapped outside of the A20 gene or in intronic sequences, 
except 2 non-synonymous SNPs in exon 3, both of which map into the DUB domain 
of the protein and result in decreased inhibitory activity of A20 and NF-κB 
hyperactivation [207]. 
Finally, it has been recently shown that a subset of SLE human patients display a 
cellular phenotype which is consistent with defects identified in sanroque mice. In 
sanroque mice abundance of TFH cells in the GCs can be monitored as proportional 
increase in circulating TFH cells. Circulating TFH, defined as ICOShiCXCR5+CD4+ cells, 
have been used as marker for GC pathway in patients with SLE and healthy controls. 
In a subset of SLE patients (5 out of 29) the absolute number of circulating TFH cells 
was increased and it has been shown to correlate with particular clinical 
manifestations as glomerulonephritis on kidney biopsy, thrombocytopenia and high 
titers of autoantibodies [208]. These results further confirm the importance of the GC 
tolerance pathway in preventing development of lupus in human patients. 
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Aim of the thesis 
Roquin is an RNA-binding protein which has been proposed to regulate a critical 
tolerance checkpoint during germinal center reactions in mice. Expansion of the 
follicular helper T cell compartment in sanroque mice, a systemic lupus 
erythematosus mouse model, was thought to be due to ectopic expression of the 
inducible costimulator ICOS, which expression is regulated by Roquin.  
The aim of this project was to investigate the precise function of Roquin in different 
compartments of the immune system, in particular B and T lymphocytes. In order to 
assess these functions in vivo, and to analyze the contribution of different Roquin 
knockout lymphocytes subsets to autoimmunity development, we generated and 
analyzed a conditional Roquin knockout model.  
Secondly, we wanted to assess the B cell intrinsic function of A20, a critical negative 
regulator of NF-κB signaling. Polymorphisms and mutations in the Tnfaip3 gene, 
encoding for A20, have been found in various human autoimmune disorders, 
including systemic lupus erythematosus. To investigate its B cell specific functions 
and its connection with autoimmune disorders, we analyzed a conditional A20 
knockout mouse model.  !
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Brief summaries of the publications 
Paper I: B cells lacking the tumor suppressor TNFAIP3/A20 display 
impaired differentiation and hyperactivation and cause 
inflammation and autoimmunity in aged mice 
The aim of this work was to clarify B cell intrinsic functions of the ubiquitin-editing 
enzyme A20, a critical negative regulator of NF-κB signaling, and to investigate a 
possible function of A20 knockout B cells in the pathogenesis of autoimmune 
disorders.  
By using a mouse model for conditional ablation of A20 specifically in B cells, we 
found that loss of A20 leads to severe defects in late B-cell development and 
differentiation. Firstly, the marginal zone B cell compartment mislocalized inside the 
follicles and marginal zone B cell precursors were expanded. However, an in vitro 
differentiation assay clearly indicated defects in the functionality of A20 knockout 
marginal zone B cells. Moreover, the numbers of B1a cells, which, together with 
marginal zone B cells, mediate innate functions of the B lineage, were reduced in B 
cell-specific A20 knockout mice. Secondly, A20 ablation caused increased germinal 
center formation in the gut-associated lymphoid tissues, where B cells are constantly 
triggered by bacterial antigens.  
A20 loss in B cells results in immune deregulation which is partially caused by B cell 
extrinsic mechanisms. Indeed, we described expansion of regulatory T, activated 
CD4 and CD8 and myeloid cells in A20 knockout mice which might be caused by 
increased production of the pro-inflammatory cytokine IL-6 by A20-deficient B cells. 
Furthermore, A20-deficiency in B cells amplified B cell responses in vitro, in 
agreement with stronger activation of the canonical NF-κB pathway induced by B cell 
receptor cross-linking, T cell costimulation and microbial components.  
Finally, we investigated the role of A20-deficient B cells in the pathogenesis of 
autoimmune disorders. The chronic inflammatory condition detected in A20 knockout 
mice results in progressive loss of tolerance which in old mice leads to autoimmune 
manifestations as formation of inflammatory infiltrates and immune complex 
deposition in kidneys and accumulation of class-switched autoantibodies in serum.  
In conclusion, loss of A20 in B cells, which results in increased NF-κB activity, 
impairs late B cell development and exacerbates B cell responses. Moreover, A20 
knockout B cells induce a condition of chronic inflammation which culminates in old 
mice in an autoimmune disorder.  
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Paper II: Loss of Roquin induces early death and immune deregulation 
but not autoimmunity 
A point mutation in Rc3h1, the gene encoding for the RNA-binding protein Roquin, 
induces a systemic lupus erythematosus-like syndrome in sanroque mice. Roquin-
mediated repression of the T cell inducible co-stimulator ICOS in follicular helper T 
cells was proposed to be instrumental to maintain tolerance within germinal centers 
preventing autoimmunity. 
To understand the function of Roquin in different populations of the immune system, 
and to elucidate whether aberrant Roquin function outside the T cell compartment 
might account for the autoimmune phenotype of sanroque mice, we generated and 
analyzed a conditional Roquin knockout mouse model. Surprisingly, loss of Roquin in 
the T cell compartment or in the entire hematopoietic system was not sufficient to 
break tolerance to self and to induce autoimmunity. Moreover, T cell development 
and T cell central tolerance checkpoints function normally in Roquin knockout thymic 
epithelial cells. To finally conclude that loss of Roquin alone is not sufficient to trigger 
autoimmunity in mice, we generated a conventional Roquin knockout mouse strain. 
Homozygous Roquin knockout mice were born at Mendelian ratios, but on the 
C57BL/6 background they died within 6h after birth. To analyze the effect of loss of 
Roquin in adult mice we backcrossed the C57BL/6 strain on a CD1 outbred 
background. Complete loss of Roquin in the CD1 outbred mouse strain was however 
still not sufficient to cause an autoimmune syndrome, indicating that the effects 
caused by the sanroque mutation are not recapitulated by absence of Roquin. 
In immune cells Roquin has several different functions. Loss of Roquin in the 
hematopoietic system causes immune deregulation, which is partially driven by 
Roquin knockout B cells. Indeed, ablation of Roquin in the B cell compartment leads 
to expansion of B lymphocytes, regulatory and effector T cells and eosinophils. In the 
T cell compartment, instead, Roquin prevents spontaneous differentiation of CD8 T 
lymphocytes towards short-lived effector cells and expansion of eosinophil and 
macrophage/monocyte populations.  
In summary, we demonstrated in this study that Roquin is a critical regulator of 
immune homeostasis, but its absence is not sufficient to recapitulate the sanroque 
phenotype and to induce autoimmunity.  
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B cells lacking the tumor suppressor TNFAIP3/A20 display impaired
differentiation and hyperactivation and cause inflammation and
autoimmunity in aged mice
Yuanyuan Chu,1 J. Christoph Vahl,1 Dilip Kumar,1 Klaus Heger,1 Arianna Bertossi,1 Edyta Wo´jtowicz,1 Valeria Soberon,1
Dominik Schenten,2 Brigitte Mack,3 Miriam Reutelsho¨fer,4 Rudi Beyaert,5 Kerstin Amann,4 Geert van Loo,5 and
Marc Schmidt-Supprian1
1Max Planck Institute of Biochemistry, Martinsried, Germany; 2Yale University School of Medicine, New Haven, CT; 3Department of Otorhinolaryngology, Head
and Neck Surgery, Grosshadern Medical Center, Ludwig-Maximilians-University of Munich, Munich, Germany; 4Universita¨tsklinikum Erlangen, Pathologisches
Institut, Abt Nephropathologie, Erlangen, Germany; and 5Department for Molecular Biomedical Research, VIB and Department of Biomedical Molecular Biology,
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The ubiquitin-editing enzyme A20/TN-
FAIP3 is essential for controlling signals
inducing the activation of nuclear fac-
tor-!B transcription factors. Polymor-
phisms and mutations in the TNFAIP3
gene are linked to various human autoim-
mune conditions, and inactivation of A20
is a frequent event in human B-cell lym-
phomas characterized by constitutive
nuclear factor-!B activity. Through B cell-
specific ablation in the mouse, we show
here that A20 is required for the normal
differentiation of the marginal zone B and
B1 cell subsets. However, loss of A20 in
B cells lowers their activation threshold
and enhances proliferation and survival
in a gene-dose–dependent fashion.
Through the expression of proinflamma-
tory cytokines, most notably interleu-
kin-6, A20-deficient B cells trigger a pro-
gressive inflammatory reaction in naive
mice characterized by the expansion of
myeloid cells, effector-type T cells, and
regulatory T cells. This culminates in old
mice in an autoimmune syndrome charac-
terized by splenomegaly, plasma cell hy-
perplasia, and the presence of class-
switched, tissue-specific autoantibodies.
(Blood. 2011;117(7):2227-2236)
Introduction
B cells play essential roles during protective immune responses to
invading pathogens. On encounter of foreign antigen and with
cognate T-cell help, B lymphocytes proliferate and form distinct
histologic structures, termed germinal center (GC). In the GC, they
undergo somatic hypermutation and class-switch recombination.
During somatic hypermutation, they introduce random mutations
into their immunoglobulin variable regions while they exchange
the heavy chain constant region during class-switch recombination
to allow for different effector functions. After a selection process
by antigen, B cells differentiate into memory B cells and plasma
cells (PCs), which secrete antibodies.1 The deregulation of this
process is heavily implicated in human disease. Production of
class-switched antibodies against self-antigens causes or contrib-
utes to various autoimmune syndromes and unrestrained B-cell
proliferation and survival can result in lymphomas.1,2 It is thought
that the majority of human lymphomas derive from the GC,
probably because the DNA damage inherent to the GC reaction
facilitates mutations and chromosomal translocations.1,3
Recently, the ubiquitin-editing enzyme A20, encoded by the
tumor necrosis factor-!-inducible gene 3 (TNFAIP3), has been
associated with both autoimmunity and lymphomagenesis. Polymor-
phisms and mutations in or near the TNFAIP3 genomic locus have
been linked with various human autoimmune syndromes with a
strong humoral component, such as systemic lupus erythematosus
(SLE),4,5 rheumatoid arthritis,6,7 and celiac disease.8 Loss of A20
function through mutations, chromosomal deletions, and/or pro-
moter methylation is a frequent event in several human lympho-
mas,9-12 all of which are characterized by constitutive activation of
nuclear factor-"B (NF-"B).13 These factors regulate a plethora of
genes encoding for proinflammatory mediators, antiapoptotic pro-
teins, cell adhesion molecules and, for negative feedback control,
inhibitory proteins, such as p100, I"B!, and A20.14,15
During the transmission of NF-"B activating signals from
cell-surface receptors such as the B-cell receptor (BCR), CD40, or
Toll-like receptors (TLRs), signal transduction occurs via the
attachment of polyubiquitin chains to key proteins, including
MALT1 or TRAF6. Polyubiquitin chains, linked via K63 or linear
assembly, serve to recruit different kinase complexes. In the case of
canonical NF-"B, induced proximity allows the upstream kinase
TAK1 to phosphorylate its target IKK2, which then effects NF-"B
activation. A20, whose transcription is induced by NF-"B, damp-
ens signaling through 2 main activities. First, as deubiquitinase
A20 removes K63-linked polyubiquitin chains from essential
signaling intermediates, such as TRAF6. Second, A20 induces, in
concert with other proteins, degradation of some of its molecular
targets, through addition of K48-linked ubiquitin chains.14,16 Degra-
dation of RIP1 limits TNF-induced signaling,14 whereas degrada-
tion of the K63-chain-specific E2 ligases Ubc13/UbcH5c generally
affects the assembly of K63-linked polyubiquitin chains.17
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To date, the main molecular action of A20 is to prevent
prolonged NF-!B activation in response to stimulation of TNF-R,
TLR-, or NOD-like receptors and the TCR.14,16 Signal con-
tainment by A20 is crucial for immune homeostasis because
A20-deficient mice die early on due to an uncontrolled inflamma-
tory disease. The inflammation is triggered via MyD88-dependent
TLRs by the commensal intestinal flora.18 To study the cell-type-
specific and cell-intrinsic roles of A20 in the mouse, we recently
generated a conditional Tnfaip3 allele (A20F).19 Given the implica-
tion of A20/TNFAIP3 in B-cell lymphomas and autoimmune
diseases, we used B lineage-specific ablation of A20 to study its
role in B-cell development, function, and disease.
Methods
Genetically modified mice
All mice described in this study are published and were originally generated
using C57BL/6 ES cells, or backcrossed to C57BL/6 at least 6 times. Mice
were housed in the specific pathogen-free animal facility of the Max Planck
Institute. All animal procedures were approved by the Regierung of
Oberbayern.
Flow cytometry
Single-cell suspensions were prepared20 and stained with monoclonal
antibodies: AA4.1(AA4.1), B220(RA3-6B2), CD1d(1B1), CD19(eBio1D3),
CD22(2D6), CD23(B3B4), CD25(PC61.5), CD3(17A2), CD38(90)
CD4(RM4-5), CD44(IM7), CD5(53-7.3), CD62L(MEL-14), CD69(H1.2F3),
CD8(53-6.7), FoxP3(FJK-16s), GR-1(RB6-8C5), IgD(11-26), IgM(II/41),
IL-10(JES5-16E3), IL-17A(eBio17B7), IL-4(11B11), IL-6(MP5-20F3),
INF-"(XMG1.2), Mac-1(M1/70), TCR-#(H57-597), TNF-$(MP6-XT22),
CD95(15A7), CD21(7G6), CD86(GL-1), CD80(16-10A1), c-kit(2B8)
(eBioscience), Ly-6G(1A8), Siglec-F(E50-2440), CD138(281-2) (BD Bio-
sciences), and PNA (Vector Laboratories).
For intranuclear FoxP3 stainings (eBioscience) according to the manu-
facturer’s instructions, dead cells were excluded with ethidium monoazide
bromide. Samples were acquired on FACSCalibur and FACSCantoII (BD Bio-
sciences) machines and analyzed with FlowJo software (TreeStar). For intracellu-
lar cytokine stainings, cells were stimulated for 5 hours at 37°C with 10nM
phorbol myristate acetate (Calbiochem), 1mM ionomycin (Calbiochem), and
10nM brefeldin-A (Applichem). Cells were treated with Fc-block (eBioscience),
and washed and surface-stained before fixation with 2% paraformaldehyde and
permeabilization with 0.5% saponin. For in vitro culture, cells were purified by
MACS (Miltenyi Biotec;% 85%-90% pure). Final concentrations of the activat-
ing stimuli: 2.5&g/mL $CD40 (HM40–3, eBioscience), 10&g/mL $IgM
(Jackson ImmunoResearch Laboratories), 0.1&M CpG (InvivoGen), 20&g/mL
lipopolysaccharide (LPS; Sigma-Aldrich), and 4 ng/mL IL-4 (R&D Systems).
Enzyme-linked immunosorbent assays were conducted using antibody pairs to
IL-6 (BD Biosciences) and TNF (BD Biosciences). Cell-cycle analyses by pro-
pidium iodide (PI) and carboxyfluorescin diacetate succimidyl ester (CFDASE)
were conducted as described.20
Real-time PCR
RNA was isolated (QIAGEN RNeasy Mini Kit) and reverse transcribed
(Promega) for quantitative real-time polymerase chain reaction (PCR)
using probes and primers from the Universal Probe Library (Roche
Diagnostics) according to the manufacturer’s instructions.
Biochemistry
B-cell whole-cell, cytoplasmic, and nuclear lysates were essentially pre-
pared as published.20 PVDF membranes were blotted with the following
antibodies: p-I!B$, p-ERK, ERK, p-JNK, JNK, p-Akt, Akt, p-p38, p38,
p100/p52 (Cell Signaling); I!B$, PLC"2, RelB, RelA, c-Rel, Lamin
B (Santa Cruz Biotechnology); tubulin (Upstate Biotechnology); p105/50
(Abcam); and A20.19
Immunofluorescence and immunohistochemistry
For immunofluorescence stainings, frozen 10-&m sections were thawed,
air-dried, methanol-fixed, and stained for 1 hour at room temperature in a
humidified chamber with B220-fluorescein isothiocyanate (eBioscience),
biotinylated rat anti-CD3 (BD Biosciences), biotinylated rat anti-CD138
(BD Biosciences), and rabbit anti–laminin (gift from Michael Sixt)
followed by Cy3-streptavidin and Cy5-conjugated anti–rabbit antibodies
(Jackson ImmunoResearch). Immunohistochemically, MZB cells were
identified by anti-CD1d (eBioscience) and metallophilic macrophages
by anti-MOMA1 (Serotec). Detection of IgG immune complexes in
paraformaldehyde-fixed kidney sections was performed using peroxidase-
labeled anti–mouse IgG antibodies and 3-amino-9-ethylcarbazole staining
(Vector Laboratories). For the detection of tissue-specific autoantibodies,
frozen sections from organs of Rag2'/' mice were incubated with sera of
aged and control mice and an anti–mouse IgG-Cy3 conjugate (Jackson
ImmunoResearch Laboratories).
Images were acquired on a Zeiss Axiophot microscope (10(/0.3 or
20(/0.75 objectives; Carl Zeiss) using a Zeiss AxioCamMRm camera (Carl
Zeiss) for monochromatic pictures and a Zeiss AxioCamMRC5 for RGB
pictures. The following software programs were employed: Axiovision release
4.8 (Carl Zeiss), Photoshop CS4 and Illustrator CS4 (Adobe Systems).
Immunizations, ELISA
Mice were immunized intraperitoneally with 10 &g NP-Ficoll (Biosearch
Technologies) and bled by the tail vein. Serum immunoglobulin concentra-
tions and NP-specific antibodies were determined by ELISA.21 The
detection of antinuclear and anticardiolipin autoantibodies was performed
using ELISA kits (Varelisa). Rheumatoid factor: ELISA plates were coated
with rabbit IgG (Jackson ImmunoResearch Laboratories).
Results
Loss of A20 leads to defects in the generation and/or
localization of mature B-cell subsets
To inactivate A20 specifically in B lineage cells at different
developmental time points and to distinguish the specific effects of
A20 ablation from potential artifacts inherent to individual cre-
transgenic strains,22 we initially investigated the consequences of
CD19cre- and Mb1cre-mediated ablation of A20 in parallel (supple-
mental Figure 1A, available on the Blood Web site; see the
Supplemental Materials link at the top of the online article).
Because we did not observe any significant differences between
CD19cre/A20F/F and Mb1cre/A20F/F mice in our experiments, we
refer to them collectively as BA20'/' mice (BA20)/' for heterozy-
gous deletion). Most of the experiments presented here were
conducted using CD19cre. Efficient loss of the NF-!B–inducible
A20 protein in B cells of these mice was confirmed by Western
blot in both resting conditions and after treatment with LPS
(Figure 1A).
Loss of A20 does not affect early B-cell development in the
bone marrow, except for a minor increase in immature B cells. In
contrast, the number of mature recirculating B cells is significantly
reduced (supplemental Figure 1C-E). BA20'/' mice have enlarged
spleens, coinciding with a minor increase in total B-cell numbers
(supplemental Figure 1B; Figure 1B), suggesting that other cell
types are also expanded. Mature follicular B-cell numbers are
unaffected by A20 deficiency, but immature transitional B cells
accumulate (Figure 1C-D) without any apparent block within the
transitional compartment (supplemental Figure 2A). The numbers
of marginal zone B (MZB) cells, defined by CD1d and CD21
expression (Figure 1C), are elevated because of an expansion of
CD23) MZB precursor cells (Figure 1E; supplemental Figure 2B).
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Inspection of the splenic follicular organization by immunofluores-
cence revealed normal B- and T-cell compartments in BA20!/!
spleens (Figure 1F). However, in BA20!/! spleen sections, CD1d-
expressing MZB cells are mostly located inside the follicle, whose
border is defined by MOMA-1-expressing metallophilic macro-
phages located adjacent to the marginal sinus. In contrast, on
BA20"/! and control spleen sections, CD1d-expressing cells are
properly located in the marginal zone (Figure 1F). Immunofluores-
cent detection of laminin and B cells indicates that the BA20!/!
splenic marginal zone is essentially devoid of B cells (supplemental
Figure 2B), further demonstrating that A20-deficient MZB cells are
not at their proper location. To test MZB cell function, we treated
splenocyte cultures with LPS for 3 days and monitored the
differentiation of short-lived plasma cells. At early times after
activation of splenic B cells by LPS MZB cells, and to much lesser
extent follicular B cells, differentiate into short-lived plasma
cells.23 As opposed to control B cells, A20-deficient splenic B cells
show a profound defect in their ability to differentiate into
Blimp1-expressing plasmablasts after LPS stimulation in vitro
(Figure 1G-H), indicating the absence or paucity of functional
MZB cells. Further underscoring this notion, BA20!/! mice display
a significant reduction in the production of class-switched, antigen-
specific IgG3 after immunizations with the TI-II antigen NP-Ficoll
(Figure 1I), a response exquisitely dependent on the presence of
MZB cells.24 These results are in line with a significant reduction of
total IgG3 serum levels in naive BA20!/! mice. IgG1 levels are also
lower in these mice, whereas IgG2c and IgG2b levels are un-
changed and IgM and IgA serum levels are strongly elevated (Figure
2A; supplemental Table 1). Supporting a role for A20 in B-cell
differentiation and/or proper localization, peritoneal B1, especially B1a
cells, are reduced in BA20!/! mice (Figure 2B; supplemental Figure 2E).
In addition, thymic B cells are reduced in BA20!/! mice, although they
appear elevated in BA20"/! mice (supplemental Figure 2D). Together,
our results uncover several surprising deficiencies in the gen-
eration, differentiation, and/or maintenance of mature B-cell subsets in
absence of A20. The affected subsets include MZB and B1 cells, which
are thought to mediate the innate functions of the B lineage.25
A20-deficiency enhances GC B-cell formation in gut-associated
lymphoid tissues
Given A20’s role as negative regulator of NF-#B signaling, we
expected A20-deficient B cells to be hyper-reactive to stimulation.
We did not observe significant spontaneous GC formation in the
spleens of the mice analyzed, indicating that spontaneous B-cell
activation, if present in these mice, is not strong enough to induce
GCs. In naive mice, gut-associated lymphoid tissue (GALT) is the
place where B cells are constantly triggered by bacterial antigens to
enter the GC.26 The percentages and, to a lesser extent, absolute cell
numbers of GC B cells in mesenteric lymph nodes and Peyer
patches are increased in BA20!/! and BA20"/! mice (Figure 2C; and
data not shown). This shows that, during B-cell activation by
bacterial antigens in the GALT, strong hemizygous effects of
A20 deficiency become apparent.
B cell–specific lack of A20 induces the spontaneous expansion
of regulatory T, effector-type T, and myeloid cells
The increase in transitional and MZB precursor cell numbers is not
sufficient to explain the higher splenocyte numbers in young
BA20!/! mice (Figure 1B). Further detailed analyses showed that
Figure 1. Conditional knockout of A20 in B cells
induces severe defects in B-cell development and
differentiation. (A) A20 protein expression in CD43-
depleted B cells after 4-hour culture with or without
10 $g/mL LPS. (B-E) Absolute cell numbers were calcu-
lated from 5 to 7 age-matched mice per genotype.
Data are mean % SD. (B) Absolute splenocyte and B-cell
numbers of the indicated genotypes. (C) Absolute cell num-
bers of splenic mature (B220"AA4.1!), marginal zone/
marginal zone precursor (MZ; MZ-P: B220"CD1dhighCD21high),
follicular (B220"AA4.1!CD1d!CD23"), and transitional
(B220"AA4.1") B cells. (D) Representative proportions
of transitional (Trans: B220"AA4.1") and mature
(B220"AA4.1!) B cells of total lymphocytes (top panels)
and of follicular (FO: CD1dintCD21int) and marginal
zone/marginal zone precursor (MZ: CD1dhighCD21high)
B cells of CD19" B cells (bottom panels) in the spleen.
(E) CD23 expression on B220"CD1dhiCD21hi B cells
(left panel). Absolute cell numbers of marginal zone
(B220"CD1dhiCD21hiCD23lo) and marginal zone precursor
(B220"CD1dhiCD21hiCD23hi) B cells (right panel). (F) Top
panels: Immunofluorescence of spleen sections: green
represents &B220, B cells; red, &CD3, T cells; and blue,
laminin. Bottom panels: Immunohistochemistry of spleen
sections: blue represents MOMA-1, metallophilic macro-
phages; and brown, CD1d-expressing cells. Bar repre-
sents 100 $m. (G) Proportions of B220loCD138hi plasma
blasts in splenic B cells 3 days after LPS treatment.
(H) Blimp1 mRNA expression relative to porphobilinogen
deaminase was determined by real-time PCR in splenic
B cells 3 days after LPS treatment. (I) Antigen-specific IgM
and IgG3 serum titers in response to T-independent im-
munizations with 10 $g NP-Ficoll determined by ELISA.
Lines represent geometric means for 5 mice per experimen-
tal group. *P ' .05 (1-way analysis of variance). **P ' .001
(1-way analysis of variance).
HYPERACTIVE A20!/! B CELLS CAUSE AUTOIMMUNITY 2229BLOOD, 17 FEBRUARY 2011 ! VOLUME 117, NUMBER 7
 For personal use only. at HINARI on February 17, 2011. www.bloodjournal.orgFrom 
homozygous and heterozygous ablation of A20 in B cells
induces elevated numbers of T and myeloid cells. The sizes of
many splenic T-cell compartments are increased in BA20!/!
mice, especially the regulatory (Figure 3A-B), memory-type and
effector-type CD4 (Figure 3B), and effector-type CD8 T cells
(Figure 3C). Similar effects on T cells were observed in the
lymph nodes (data not shown). The analysis of ex vivo T-cell
cytokine production by intracellular staining revealed compa-
rable proportions of IL-17–, interferon-"– and TNF-producing
cells between BA20!/! and control mice (Figure 3E). We were
unable to detect any IL-4-producing cells (not shown). These
analyses suggest the absence of detectable T-cell differentiation
into specific T-helper lineages. The cell numbers of all splenic
myeloid subsets analyzed were higher in BA20!/! compared
with control mice, with significant increases in dendritic cells
and eosinophils (Figure 3D). Importantly, heterozygous loss of
A20 in B cells induces an intermediate phenotype (Figures
3A-D) in most aspects of this immune deregulation. BA20#/!
mice contain even higher proportions of splenic regulatory and
effector T cells than BA20!/! mice (Figure 3A). However, the
higher absolute cell numbers of total CD4 T cells in BA20!/!
mice leads to the greatest absolute cell numbers also in these
subsets (Figure 3B). BA20!/! and BA20#/! mice contain elevated
proportions of IL-10–producing B cells (supplemental Figure
2C), excluding the possibility that absence of this immune-
regulatory B-cell subset27 causes the perturbation in immune
homeostasis. To validate that CD19cre mediates inactivation
of A20 alleles only in B cells, we performed PCR on DNA
purified from splenic cell subsets of BA20!/! mice. The purified
T cells, dendritic cells, macrophages, and granulocytes contain
less than 0.2% A20-knockout cells, which could be contami-
nating B cells (supplemental Figure 3). Our findings therefore
indicate that the absence or gene-dose reduction of A20, spe-
cifically in B cells, induces an immune deregulation reminiscent
of sterile inflammation, possibly held in check by regulatory
lymphocyte subsets.
Figure 2. A20-deficiency impairs B1 cell generation
but enhances GC formation in the GALT. (A) Titers of
immunoglobulin isotypes were determined by ELISA;
n $ 6 to 12 per genotype. (B) Absolute cell numbers of
B-cell subsets in the peritoneal cavity: B2 (CD19#B220#),
B1 (CD19highB220low), B1a (CD19highB220lowCD5#), and
B1b (CD19highB220lowCD5!) cell numbers were calcu-
lated from 5 to 7 age-matched mice per genotype. Data
are mean % SD. (C) Left panel: Proportions of GC
(CD19#PNAhiFashiCD38lo) of total B cells in Peyer patches.
Data are mean% SD of 8 mice per genotype. Right panel:
Proportions of GC B cells depicted as individual data
points (left chart), absolute cell numbers for naive B cells
(mantle zone B cells: CD19#PNA! Fas!CD38hi; middle
chart), and GC B cells (right chart). Bars represent medi-
ans of 8 mice per group (same as in the left panel).
*P & .05 (1-way analysis of variance). **P & .001 (1-way
analysis of variance).
Figure 3. Ablation of A20 in the B-lineage has
B cell-extrinsic effects on immune homeostasis.
(A) Dot-plots showing percentages of CD4#Foxp3# regula-
tory T cells and CD4#CD25! T cells (naïve indicates
CD44intCD62Lhi; memory, CD44hiCD62Lhi; and effector,
CD44hiCD62Llo) in the spleen. Numbers indicate the mean
of 4 to 6 mice for each genotype. (B-D) Absolute cell
numbers of CD4 T (B), CD8 T (C), and myeloid cell
(D) subsets in BA20!/!, BA20#/!, and CD19cre mice (n $ 6
per group; 8-12 weeks old). Data are mean % SD. Treg
indicates Foxp3#; naive, CD44intCD62Lhi; memory,
CD44hiCD62Lhi; effector/memory, CD44hiCD62Llo; DC, den-
dritic cell (CD11c#); Eos, eosinophils (Gr1intSiglecF#); Mac,
macrophages (Mac1#Gr1lo); and Neu, neutrophils
(Gr1hiLy6G#). (E) Intracellular cytokine staining of ex vivo
isolated splenocytes (gated on T cells). Numbers represent
mean plus or minus SD of 3 mice per genotype. *P & .05
(1-way analysis of variance). **P & .001 (1-way analysis of
variance).
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A20 regulates B-cell responses in vitro in a
gene-dose–dependent fashion
Our observations of enhanced GC B-cell formation in the GALT in
BA20!/! and BA20"/! mice suggested the possibility that their
B cells are more easily activated in this context. To analyze this in
more detail, we first quantified the relative A20 mRNA expression
at different time points after activation with #IgM, #CD40, LPS,
CpG DNA, and TNF. All these stimuli induced a strong increase in
A20 mRNA, peaking at approximately 1 hour (supplemental
Figure 4A), prompting us to test the in vitro responses of purified
A20-deficient and A20"/! B cells to these mitogens. B cells
up-regulate certain cell surface molecules (activation markers)
upon activation, among them B7.1/CD80, B7.2/CD86, MHC II,
CD25, and Fas. The expression of these markers was already
slightly higher in unstimulated B cells purified from BA20!/! and
BA20"/!mice compared with control B cells (Figure 4A; supplemen-
tal 4B). This is probably because of the latent immune activation
we observed in these mice. Upon activation with the indicated
mitogens, A20-deficient B cells produced higher surface levels of
many activation markers (Figure 4A; supplemental Figure 3B).
B cells carrying one functional A20 allele showed an intermediate
phenotype regarding expression of these activation markers (Figure
4A). We then monitored #IgM-, #CD40-, LPS-, and CpG DNA-
induced proliferation by 3 assays: Both [3H]thymidine incorpora-
tion (Figure 4B) and cell cycle analysis (Figure 4C) showed increased
proliferative activity in the A20-deficient B-cell cultures in response to
all stimuli, and quantification of live cells revealed increased survival
after all stimuli, except for CpG DNA (Figure 4C). By CFSE dilution
assay (Figure 4D), we determined that the absence of A20 increased the
proportion of B cells that initially start to divide (% divided) in response
to #CD40 and LPS. Only CpG DNA and BCR crosslinking
enhanced the proliferation of dividing A20-deficient B cells
(Proliferation Index; Figure 4D). Combination of stimuli, such as
LPS and #IgM, or the addition of IL-4, did not yield additive
effects (supplemental Figure 4C). In all stimulations, the magni-
tude of the A20"/! B-cell response was in between A20!/! and
control B cells (Figure 4B-D). Taken together, our studies show
that reduction of A20 function magnifies B-cell responses through
3 mechanisms, depending on the activating stimulus: lowering the
threshold for initial activation (#CD40, LPS), protecting activated
B cells against apoptosis (#IgM, #CD40, LPS), and enhancing the
proliferation of cells that were activated to divide (#IgM, CpG).
Figure 4. A20-deficiency amplifies B-cell responses.
(A) Expression levels of the respective B-cell activation
marker after overnight stimulation with LPS or #CD40. The
dot-plots are representative of 3 to 6 independent experi-
ments. (B) [3H]Thymidine incorporation during a 10-hour
pulse 48 hours after stimulation of B-cell cultures with
#IgM, #CD40, LPS, or CpG. Data are mean $ SD of
triplicate measurements. The experiment was repeated
with similar results. (C) Cell cycle profile analysis by
propidium iodide staining of B cells 2 days after stimulation
with the indicated mitogens. Percentages of dead (sub G0)
and live cells are indicated at the top of each histogram.
The distribution within the cell cycle was calculated with
the FlowJo software Version 8.7.3 using the Watson model
(values do not add up to 100%). Data are means of
2 independent experiments. (D) Assessment of prolifera-
tion by the carboxyfluorescein succinimidyl ester dilution
assay: histograms represent carboxyfluorescein succinimi-
dyl ester intensities 3 days after stimulation. The tables
under each histogram show the proliferation index (Prol.
Index: average number of divisions of the proliferating
cells), the percentage of dividing cells (% Divided: the
proportion of cells that initially started to divide), and the
division index (Div. Index: average number of divisions of
all cells); values were calculated with the FlowJo software.
Data represent the means of 5 independent experiments,
and bold values are significantly different (P % .05) from
wild-type according to 1-way analysis of variance analysis.
(E) Evaluation of IL-6 production in overnight activated B
cells by ELISA (top panels), intracellular FACS (middle
panels), and real-time PCR (bottom panels). For intracellu-
lar FACS, B cells were stimulated for 3 days. cDNA was
quantified relative to porphobilinogen deaminase. Data
are mean$ SD of 3 independent experiments. (F) Quanti-
fication of TNF production by overnight-stimulated B cells
via ELISA. Data are mean $ SD of 3 independent
experiments.
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A20-deficient B cells exhibit spontaneous IL-6 secretion and
highly elevated IL-6 secretion on activation
In light of the T effector and myeloid cell expansion, we wondered
whether the higher excitability of A20-deficient B cells leads to
secretion of proinflammatory cytokines, which in turn affect the
differentiation and expansion of immune cells. IL-6 is a pleiotropic
cytokine with inflammatory activity, and its levels are up-regulated
in various autoimmune diseases, such as rheumatoid arthritis and
SLE.28 Activated A20-deficient B cells produced dramatically more
IL-6 mRNA and protein than control B cells in response to all
mitogens (Figure 4E). We could again detect an intermediate
phenotype in A20!/" B cells (supplemental Figure 4D). Indeed,
A20-deficient B cells spontaneously produced and released IL-6
into the cell culture medium in the absence of stimulation in
comparable amounts to the IL-6 secretion in #IgM-stimulated
control B cells (Figure 4E). A20-deficient B cells also produced
slightly more TNF in response to all stimuli (Figure 4F). In accord
with these findings, we detected more IL-6 and TNF-producing
cells in ex vivo isolated A20-deficient compared with control
B cells (supplemental Figure 4E). The evaluation of IL-6 produc-
tion in immune cell subsets of 3- to 4-month-old BA20"/" mice by
intracellular flow cytometry and real-time PCR revealed that, in
addition to B cells, dendritic cells and, to a lesser extent,
macrophages also produce IL-6 (supplemental Figure 5). This
suggests that secondary activation of myeloid cells by A20-
deficient B cells exacerbates the immune deregulation in
BA20"/" mice.
A20 negatively regulates canonical NF-!B, but not MAPK or
AKT activation, in response to engagement of the
BCR, CD40, and TLRs
We established that A20 is a gene-dose–dependent negative
regulator of B-cell activation in response to triggering of the BCR,
CD40, and TLRs. A20 was reported to limit the activation of
canonical NF-$B in response to various stimuli in other cell
types.14,16 Therefore, we wanted to confirm that the hyper-reactivity
of A20-deficient B cells also correlates with enhanced canonical
NF-$B activity in response to the stimuli used in our study. Indeed,
the absence of A20 selectively enhances the activation of the
canonical NF-$B pathway, evidenced by prolonged increased
I$B# phosphorylation and degradation (Figure 5A-C). The activa-
tion of MAPK pathways or AKT phosphorylation was unaltered in
response to #IgM, LPS, and #CD40 (Figure 5A-C). The increased
I$B# phosphorylation correlated well with an increase in nuclear
translocation of p50 and RelA 2 and 4 hours after activation with
#CD40 (Figure 5D). We detected elevated expression of p100 and
RelB, substrates of the alternative NF-$B pathway and transcrip-
tional targets of canonical NF-$B in whole cell extracts of
A20-deficient B cells (data not shown) in accord with the higher
canonical NF-$B activity in these cells. Taken together, although
we do not rule out that A20 has additional functions, we demon-
strate that deficiency for A20 in B cells strongly enhances
activation of the canonical NF-$B pathway in response to BCR
cross-linking (antigen), T-cell costimulation (#CD40), and micro-
bial components (TLRs).
Figure 5. A20 controls canonical NF-!B activation in
response to B-cell mitogens. (A-C) Western blot of whole
cell lysates stimulated for the indicated time points with
(A) 10 %g/mL #IgM, (B) 20 %g/mL LPS, and (C) 10 %g/mL
#CD40. (D) Western blots on cytoplasmic and nuclear
extracts after stimulation with #CD40. Results are represen-
tative of 2 or 3 independent experiments.
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Loss of A20 in B cells leads to autoimmune pathology in
old mice
To assess the impact of the chronic proinflammatory state induced
by B cell-specific loss of A20 in old age, we aged a cohort of
BA20!/! and control mice. Histologic analysis of organs from
20-week-old BA20!/! mice did not yield any signs of inflammation
(not shown). BA20!/! mice, more than one year old, on the contrary,
were characterized by splenomegaly (Figure 6A; supplemental
Figure 6A-B). Although total B-cell numbers were not significantly
elevated in old BA20!/! compared with control mice, all A20!/!
B cells appeared activated, as judged by the larger cell size and
elevated levels of the activation marker CD69 (Figure 6B). In
addition, we observed a marked expansion of PCs in the spleen
(Figure 6C; supplemental Figure 6C), but not in the bone marrow
(data not shown). Immunofluorescence analysis of the enlarged
spleens revealed a diffuse pattern of PCs surrounding altered and
disrupted B-cell follicles (Figure 6D). Analysis of the serum
isotype titers in aged BA20!/! mice revealed higher IgM titers
compared with controls, as seen in young mice. However, in
contrast to the latter, in old BA20!/! mice the levels of the
pathogenic IgG2b isotype29 are elevated (Figure 6E; supplemental
Table 2). The increase of effector and regulatory T cells, already
apparent in young BA20!/! mice, has further expanded in old mice,
at the expense of the respective naive compartments (Figure 6F-G).
In addition, the expansion of myeloid cell subsets was much more
pronounced (Figure 6H). The progressive nature of the inflamma-
tion in the BA20!/! mice is also reflected in elevated levels of serum
IL-6 in aged BA20!/! mice (Figure 6I), which could not be detected
in the 20-week-old BA20!/! mice (not shown). Histologic analysis
of organs from aged mice revealed inflammatory infiltrates in the
liver and kidney of most of the old BA20!/! mice (supplemental
Figure 6D). Examinations of the renal pathology revealed no
extensive glomerular damage but clear IgG immune complex
depositions in aged BA20!/! mice (Figure 6J).
Given this finding, we tested the sera of all old BA20!/! and
control mice for indicators of self-recognition. Class-switched
antibodies against nuclear self-antigens (ANAs) are the most
common autoantibodies observed in autoimmune conditions in
mice and humans.30 Sera from BA20!/! mice did not contain
significantly higher ANA levels than sera from the controls, and we
also did not detect enhanced reactivity to endogenous red blood
cells (Figure 7A). In addition, we observed increased levels of
rheumatoid factor of the IgM isotype in some BA20!/! mice, but not
of the IgG isotype (Figure 7A). However, we detected significantly
elevated amounts of anticardiolipin IgG antibodies in aged BA20!/!
mice (Figure 7A), demonstrating systemic class-switched autoim-
mune reactivity. To evaluate whether antiphospholipid antibodies
are already detectable in younger mice, we screened the sera of
3-month-old mice. We detected elevated anticardiolipin IgG anti-
bodies in sera from BA20!/! mice (and BA20"/! mice) compared
with control sera, but the differences were not statistically signifi-
cant (Figure 7C).
To screen for further autoreactivity against potentially tissue-
specific self-antigens, we incubated organ sections of Rag2!/!
mice with the sera of the aged mice. We detected autoreactive
class-switched IgG antibodies in the sera of BA20!/!, but not of
Figure 6. Splenomegaly and plasma cell hyperplasia in old
BA20!/! mice. Cohort description: age range, 60 to 85 weeks;
mean age of experimental group, 68 weeks; mean age of control
group, 66 weeks. (A) Absolute cell numbers of splenocytes
(n(BA20!/!) # 10, n(control) # 9). (B) Left panel: Absolute cell
numbers of B cells (CD19"; n(BA20!/!) # 12, n(control) # 11).
Right panel: Representative size and CD69 expression of splenic
B220" B cells. (C) Absolute cell numbers of splenic plasma cells
(B220loCD138hi; n(BA20!/!) # 10, n(control) # 9). (D) Representa-
tive immunofluorescence analysis of plasma cells in the spleen,
plasma cells (red represents $CD138), B cells (green represents
$B220). Bar represents 100 %m. (E) Titers of immunoglobulin
isotypes in aged mice were determined by ELISA; n(BA20!/!)
# 12, n(control)# 11. (F-H) Absolute splenic cell numbers for the
following cellular subsets: CD4 T cells. (F) Treg (CD4"CD25"); CD4"
naive (CD25!CD44intCD62Lhi), memory-type (CD25!CD44hiCD62Lhi),
and effector T (CD4"CD44hiCD62Llo); CD8-T cells. (G) Naive
(CD44intCD62Lhi), memory-type (CD44hiCD62Lhi), and effector
T (CD44hiCD62Llo); myeloid cells (H): DC indicates dendritic cell
(CD11c"); Eos, eosinophils (Gr1intSiglecF"); Mac, macrophages
(Mac1"Gr1lo); and Neu, neutrophils (Gr1hiLy6G"). n(BA20!/!)# 5,
n(control)# 5. (I) Serum IL-6 (pg/mL) in aged mice was measured by
ELISA; n(BA20!/!)# 12, n(control)# 11. (J) Representative stainings
of IgG immune complexes in kidneys of BA20!/! and control mice.
Original magnification& 20. *P' .05 (1-way analysis of variance).
**P' .001 (1-way analysis of variance).
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control mice, directed predominantly against kidney, harderian
gland, stomach, thyroid gland, eye, liver, and lung (Figure 7B;
supplemental Figure 6E). Pancreas, salivary, lacrimal, and adrenal
glands were also recognized by sera from few BA20!/! mice but
with a lower penetrance compared with the organs mentioned
earlier (Figure 7B). Notably, the kidney was recognized by
autoantibodies in the sera of the majority of BA20!/! mice.
Therefore, we conclude that A20-deficient B cells induce chronic
progressive inflammation, which results in significant autoimmune
manifestations and pathologic alterations in old mice.
Discussion
The prevalent inactivation of the ubiquitin-editing enzyme A20 in
human B-cell lymphoma and the linkage of polymorphisms in the
A20/TNFAIP3 gene to human autoimmune diseases raise the
question of its function in the B-lineage, especially during B-cell
activation.
The major molecular function of A20 uncovered to date is the
negative regulation of canonical NF-"B activation.14 We confirm
that, also in B cells, A20 limits activation of this signaling pathway
by all relevant physiologic inducers. Constitutive activation of
canonical NF-"B in B cells induces B-cell hyperplasia, especially
pronounced in MZB cells.20 In contrast, we uncovered that
A20 activity is required for the correct localization of MZB cells
and for MZB cell function. Therefore, we conclude that proper
differentiation of A20-deficient MZB cells does not take place. In
addition, A20 is needed for the generation or cellular maintenance
of peritoneal B1, bone marrow recirculating and thymic B cells,
either directly or by mediating their correct localization. Reduced
cellular maintenance could be caused by lower sensitivity to
survival signals available in naive mice, but also by increased
terminal differentiation because of their hyperactivatable state. The
elevated IgA serum levels could be a consequence of the enhanced
GC reactivity in the GALT of BA20!/! mice. Another possible
explanation is that the lower levels of B1a cells could, at least in
part, be caused by their enhanced differentiation to IgA-producing
plasma cells in response to inducing signals, such as IL-15,31 a
cytokine known to induce NF-"B activation. This phenomenon
could also contribute to the elevated IgM levels. Because B1 cells
are thought to be the main source of naturally occurring autoanti-
bodies in naive mice,32 this could signify that also natural
autoantibody IgM titers, which are not pathogenic but rather play a
protective role, are enhanced in the BA20!/! mice. The accumula-
tion of A20-deficient precursor populations (transitional B cells and
MZB cell precursors) points to blocks in development, although we
cannot exclude a role for impaired negative selection.
Taken together, our data on B-cell development and in vitro
activation studies suggest the following: A20 activity is required to
limit acute B-cell activation induced by stimuli connected to
invasion by pathogens. Its absence reduces the activation threshold
and enhances survival and proliferation in response to such stimuli.
On the other side, the absence of A20 does not render B cells more
responsive to maintenance signals required for mature resting cells.
Increased B cell–mediated IL-6 secretion resulting from spo-
radic local activation and, at least in the case of A20 deficiency,
spontaneous production and release of IL-6 is a probable underly-
ing cause of the effector T-cell differentiation and myeloid cell
hyperplasia that we observed in BA20!/! and BA20#/! mice.
Subsequent cytokine secretion by activated myeloid cells most
probably amplifies this response. Indeed, Tsantikos et al recently
showed that effector T-cell activation, myeloid cell expansion, and
the development of autoimmune disease in Lyn-deficient mice,
which strikingly resemble BA20!/! and BA20#/! mice in this regard,
are entirely dependent on the secretion of IL-6.33 Interestingly, the
authors also observed expansion of CD4#CD25# T cells but did
not investigate whether they represent activated or regulatory
Figure 7. Autoimmune manifestations in old BA20!/!mice.
(A) Analysis of autoantibodies in aged mice. ANA indicates
that antinuclear IgG antibodies were detected by ELISA,
n(BA20!/!) $ 12, n(control) $ 21; %RBC-IgM, antierythrocyte
IgM was detected by FACS and represented as mean
fluorescence intensity, n(BA20!/!) $ 8, n(control) $ 4. IgG
and IgM rheumatoid factor (RF) was measured by ELISA;
n(BA20!/!) $ 12, n(control) $ 11. %-Cardiolipin IgG antibod-
ies were detected by ELISA; n(BA20!/!) $ 12, n(control) $ 11.
*P & .05 (2-tailed unpaired Student t test). **P & .001
(2-tailed unpaired Student t test). (B) Table depicting the
self-reactivity of sera from individual BA20!/! mice against the
indicated organs from Rag2!/! mice. #, ##, and ###
indicate the severity of autoreactivity; and n.s., not screened.
(C) Levels of %-cardiolipin IgG autoantibodies in 3-month-old
mice (left panel; n $ 8 per genotype) and in 11-month-old
mice (right panel; n $ 5 per genotype) were detected by
ELISA. *P & .05 (1-tailed unpaired Student t test).
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T cells.33 The enhanced numbers of Tregs we observe in the
BA20!/! and BA20"/! mice appear paradoxical in the context of
elevated IL-6 levels.34 We suggest that they expand and/or are
induced in reaction to the IL-6-driven inflammation. However, the
presence of IL-6 increases the resistance of effector T cells to
suppression by regulatory T cells,35 both systemically and locally.
Expansion of Tregs has also been observed in the BWF1 mouse
model for human SLE.36 Whether, and to what extent, an expanded
Treg population serves to keep the sterile inflammation in check is
an intriguing question to be tested in future studies.
While this manuscript was in preparation, a study by Tavares et
al on the same topic was published.37 The authors also found a
convincing gene-dose–dependent effect of A20 ablation on B-cell
activation. They detected elevated levels of antibodies in the serum
of CD19cre/A20F/F mice that recognize self-antigens on a protein
array. However, in their approach, anti–mouse Ig was used to detect
autoantibodies, which also recognizes IgM. Indeed, both studies
find highly elevated titers of IgM in naive BA20!/! mice (in our
case, a 10-fold difference in the geometric mean). Naturally
occurring autoantibodies are mostly of the IgM isotype.38,39
Therefore, the increased recognition of self observed by Tavares et
al37 could reflect, at least to some degree, this increase in natural
autoantibodies. This possibility is substantiated by the fact that
only IgM" dsDNA-recognizing plasma cells were detected and that
IgM immune complex deposits were revealed in naive 6-month-old
mice, in the absence of any sign of pathology.37 Given that the role
of IgM autoantibodies is also discussed as being protective,38,39 it is
unclear whether the autoreactivity observed in younger mice
contributes to the development of, or helps to prevent, disease.
We observed significant autoreactivity of class-switched antibod-
ies only in old mice, together with autoimmune pathology
and inflammation. The chronic inflammation induced by the
A20-deficient B cells perhaps contributes to a progressive break in
B-cell tolerance resulting in the production of class-switched,
autoreactive antibodies. The immune senescence of old age might
also contribute to this break in tolerance.32 The inflammatory
microenvironment in the spleen, and potentially in other affected
organs, together with the elevated presence of the pleiotropic
cytokine IL-6, may serve as a niche for the (autoreactive) plasma
cells. However, we do not detect significant levels of IgG ANAs,
the hallmark of SLE.30 Instead, we observe general IgG autoreactiv-
ity to cardiolipin, a common autoantigen in autoimmune dis-
ease30,40 in old BA20!/! mice. The presence of tissue-specific
class-switched autoantibodies strongly underscores the loss of
tolerance. Some pathologic features of the old BA20!/! mice are
reminiscent of human Castleman disease, namely, massive infiltra-
tions of plasma cells and the elevated presence of IL-6.28,41 It is
indeed possible that the disturbed B-cell development, including
the elevated levels of naturally occurring auto-IgM, are preventing
a more severe syndrome. Heterozygous BA20"/! mice display
inflammation and B-cell hyper-reactivity, but no developmental
defects. Therefore, they might represent a good tool for modeling
the reduced expression or function of A20 that should underlie the
link between mutations and polymorphisms in A20/TNFAIP3 and
human autoimmune disease. Indeed, initial analyses revealed
elevated class-switched antibodies against cardiolipin in a cohort of
11-month-old BA20"/! mice (Figure 7C).
We demonstrate here that selective loss of A20 in B cells is
sufficient to cause an inflammatory syndrome with autoimmune
manifestations in old mice. This condition is characterized by a
progressive chronic inflammation, elevated levels of IL-6, dramatic
plasma cell expansion, and the presence of class-switched systemic
and tissue-specifc autoantibodies. The exquisite dose effects of
monoallelic loss of A20 make it a prime target for deregulation by
proinflammatory miRNAs and oncomirs in disease contexts. Our
results demonstrate that B-cell hyper-reactivity caused by reduced
A20 function can contribute to the observed link between inherited
genetic mutations or polymorphisms in A20/TNFAIP3 and various
human autoimmune diseases.
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Cell purification and flow cytometry 
The purification of lymphocyte and leukocyte subsets was achieved by a two step 
procedure. Splenic cell suspensions were first separated into CD43-expressing and 
CD43-negative fractions by MACS (Miltenyi). The CD43-negative fraction was stained 
with antibodies against B220 (eBioscience) and CD19 (eBioscience) and B220+CD19+ 
B cells were purified using a FACSAria (BD). The CD43-positive fraction was stained 
with antibodies against B220, TCRȕ, CD11c, Gr-1 and Mac1 (all eBioscience). The 
following subsets were purified by FACS: T cells (B220íTCRȕ+), dendritic cells 
(B220íTCRȕíCD11c+), granulocytes (B220íTCRȕíCD11cíGr1+Mac1lo) and 
macrophages (B220íTCRȕíCD11cíGr1loMac1hi). All cell populations were over 99% 
pure. 
 
For intracellular ex vivo IL-6 stainings of lymphocytes and leukocyte subsets, cells were 
stimulated for 5 h at 37°C with 10 nM brefeldin-A (Applichem). 
 
PCR to identify A20 knock-out cells 
PCR was performed using the primers a (CATTTAACCCTTCTGAGTTTCCA), b 
(CCGGGCTTTAACCACTCTC), c (CCACCCCTATTACTACGTGACC) and the following 
touchdown program: (1) 95°C 3min, (2) 95°C 30s, (3) 65°C 45s, (4) 72°C 60s, while 
steps (2)–(4) are repeated 10 times, the annealing temperature is decreased by 
1°C/cycle, until 55°C is reached; (5) 95°C 30s, (6) 55°C 45s, (7) 72°C 60s, (5)–(7) are 
repeated 20 times; (8) 72°C 5min, (9) 4°C 15min. The PCR was conducted with either 
all three primers or only two (b, c) to specifically amplify the A20-knockout allele. PCR 
was performed on DNA isolated from the purified cell subsets. To estimate the 
sensitivity of the PCR for the knockout allele, we diluted DNA from CD19cre/A20F/F B 
cells at different ratios in DNA from A20F/F macrophages. 
 
Immunohistochemistry 
Spleen, kidney, liver were fixed in 4% PFA, processed, and embedded in paraffin. 2-ȝm 
sections for PAS stainings were prepared according to routine protocols. For the 
detection of tissue-specific autoantibodies, frozen sections from organs of Rag2í⁄í mice 
were incubated with sera of aged and control mice and an anti–mouse IgG–Cy3 
conjugate (Jackson ImmunoResearch). 
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Figure S1. Loss of A20 B-lineage cells leads to decreased numbers of 
recirculating B cells in the bone marrow 
(A) Scheme of B cell development and developmental time-frame (depicted as arrow), 
during which Mb1cre and CD19cre mouse strains express the cre recombinase. 
CD19cre induces partial recombination in preB and immature B cells: dotted line. (B) 
Representative spleen sizes of 8–12-week-old age-matched mice. (C) Representative 
dotplots showing proportions of pre/pro (B220+IgMí), immature (B220loIgM+) and 
mature/recirculating (B220hiIgM+) B cells of lymphocytes (upper panels) and pro (proB: 
CD25íc-Kit+) and pre (preB: CD25+c-Kití) B cells of B220+IgMí cells (lower panels) in 
the bone marrow. (D) Absolute cell numbers of lymphocyte subsets in the bone marrow: 
total bone marrow cells, B cells (B220+), proB, preB, immature B and recirculating B 
cells (defined as in C). Values represent means and s.d. calculated from 5–6 mice per 
genotype. (E) Effects of Mb1cre-mediated ablation of A20 on B-lineage cells in the bone 
marrow: upper two sets of panels as in (C), lower panels: percentages of large 
(B220hiIgM+CD25+c-KitíFSChi) preB of total preB cells. * = p < 0.05; ** = p < 0.001; one-
way anova 
 
Figure S2. Loss of A20 B-lineage cells leads to an accumulation of transitional B 
cells in the spleen 
(A) Representative dotplots showing proportions (left) and bar charts with absolute cell 
numbers (right) of B220+AA4.1+ transitional B cell subsets in the spleen: IgMhiCD23í T1, 
IgMhiCD23+ T2 and IgMloCD23+ T3 (anergic). Values represent means and s.d. 
calculated from 5–6 mice per genotype. (B) Upper panels: representative dotplots 
showing proportions of CD19+CD21hiCD1dhi B cells in the spleen: CD23lo MZ and 
CD23hi MZ precursor B cells. Values represent means and s.d. calculated from 5–6 
mice per genotype. Lower panels: immunofluorescence of spleen sections 
demonstrating the marginal sinus (depicted as dotted yellow line) as border between the 
marginal and follicular zone: green = ĮB220, B cells; red = ĮCD3, T cells; blue = 
laminin. Magnification: 20×. (C) Representative dotplots showing proportions of IL-10 
producing B cells (B220+IL10+) after 5h stimulation with PMA/ionomycin/BFA/LPS. 
Values represent means and s.d. of 3 mice per genotype. (D) Representative dotplots 
showing proportions of B cells in the thymus (B220+TCRȕí). Values represent means 
and s.d. of 3 mice per genotype. (E) Representative dotplots showing proportions of B 
cell subsets in the peritoneal cavity (absolute cell numbers are shown in Fig. 2B): 
B220hiCD19+ B2 and B220loCD19hi B1 cells of total lymphocytes (upper panels) and 
CD43loCD5í B1b and CD43+CD5+ B1a cells of B1 cells (lower panels). * = p < 0.05; ** = 
p < 0.001; one-way anova 
 
Figure S3. Fidelity of CD19cre for specific recombination of conditional A20 
alleles only in B cells 
(A) Scheme of the conditional A20 allele before (upper panel) and after (lower panel) 
cre-mediated recombination. The location of the primers (a–c) employed for the 
genotyping PCR are shown and the length of the respective PCR amplification 
products. Squares indicate exons (E3–E7) and triangles loxP sites. (B) Upper panels: 
representative PCR results for two PCR reactions on DNA from purified splenic cell 
subsets: the three primer PCR (a, b, c) amplifies A20 loxP-flanked and knockout alleles, 
whereas the two primer PCR (a, c) amplifies only DNA from A20-knockout alleles. 
Splenic cell subsets (T cells = B220íTCRȕ+, dendritic cells/DC = B220íTCRȕíCD11c+, 
macrophages/Mac = B220íTCRȕíCD11cíGr1loMac1hi and granulocytes/Gr = 
B220íTCRȕíCD11cíGr1+Mac1lo) were MACS purified followed by cell sorting and were 
over 99% pure. Identical results were obtained for all the cellular subsets sorted from 
three individual CD19cre/A20F/F mice. Lower panels: evaluation of the sensitivity of the 
two PCRs. A20-knockout cells were diluted at different ratios with A20F/F cells. The 
PCRs are able to amplify the knockout allele at a dilution of 1 to 500. The amplification 
product for the knockout allele that could be observed with the DNA from purified T 
cells, DCs, macrophages and granulocyte was weaker than the amplification product 
from the 1:500 A20-knockout to A20F/F dilution in all cases. This band therefore 
represents most likely the presence of less than 0.2% contaminating B cells in the 
respective purified cell-type. However, this analysis does not allow us to rule out the 
presence of less than 0.2% A20-knockout cells within each cell-type. 
 
Figure S4. A20 regulates B cell activation in a dose-dependent fashion 
(A) Realtime PCR quantifying the amount of A20 mRNA relative to PBGD mRNA in 
wild-type B cells stimulated with the indicated mitogens for 1, 4 and 12 h. Means and 
s.d. of triplicate measurements are shown. (B) Expression levels of the B cell activation 
marker after o/n stimulation with ĮIgM, LPS, CpG or ĮCD40. The dotplots are 
representative of 3 independent experiments. (C) Assessment of proliferation by the 
CFSE dilution assay: histograms show CFSE intensities 3 days after stimulation with 
the indicated mitogens. The table depicts the proliferation index (Proliferation index: 
average number of divisions of the proliferating cells), the percentage of dividing cells 
(% Divided: the proportion of cells that initially started to divide) and the division index 
(Div. Index: average number of divisions of all cells). Numbers represent the means of 3 
to 4 (ĮCD40/IL-4) independent experiments. (D) IL-6 levels were measured in the 
supernatant after o/n stimulation with ĮIgM, LPS, CpG or ĮCD40. (E) Representative 
dotplots showing proportions of TNFĮ- or IL-6–producing B cells (B220+ TNFĮ+ or 
220+ IL-6+) after 5h stimulation with PMA/ionomycin/BFA. Values represent means 
nd s.d. of 3 mice per genotype. 
B
a

Figure S5. IL-6 producing cell-types in CD19cre/A20F/F mice 
(A) Realtime PCR analysis of IL-6 expression in FACS-purified splenic cell subsets of 
CD19cre/A20F/F and CD19cre control mice. Splenic cell subsets (T cells = B220íTCRȕ+, 
dendritic cells/DC = B220íTCRȕíCD11c+, macrophages/Mac = 
B220íTCRȕíCD11cíGr1loMac1hi and granulocytes/Gr = 
B220íTCRȕíCD11cíGr1+Mac1lo) were MACS purified followed by cell sorting and were 
over 99% pure. IL6 cDNA was quantified relative to PBGD. Values represent means 
and s.d. of 3 independent experiments. (B) Proportions of IL-6 expressing cells of 
individual immune cell subsets in the spleen of CD19cre/A20F/F and CD19cre control 
mice identified by intracellular FACS. Values represent means and s.d. of 3 
independent experiments. 
 
Figure S6. Chronic inflammation and autoreactivity in aged BA20í⁄í mice 
(A) Representative spleen size of old CD19cre/A20F/F and age-matched CD19cre 
control mice. (B) Spleen weight (n(BA20í⁄í) = 10, n(control) = 9). (C) Representative 
dotplot showing proportions of plasma cells (B220loCD138hi), mean and s.d. for n = 9 
mice per genotype are shown. (D) Representative PAS stainings of liver and kidney 
sections from aged mice. Magnification: 10×. (E) Representative immunofluorescence 
staining of tissue-specific IgG autoantibodies directed against kidney, harderian gland, 
stomach and lacrimal gland. Staining was performed by incubating sera from aged mice 
on sections of tissues isolated from Rag2í⁄í mice. Magnification: 20×. 
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Brief Definit ive Report
Autoimmunity occurs when immune e!ector 
mechanisms, normally used to protect organisms 
against invading pathogens, are unleashed onto 
self-constituents. Most autoimmune diseases are 
complex, multifactorial processes, reflecting 
the number and the nature of checkpoints that 
have to be overcome (Goodnow, 2007).
Only a small number of critical proteins 
appear to play such central roles in the mainte-
nance of immunological self-tolerance that alter-
ations in their function strongly predispose to a 
rapid development of autoimmune syndromes. 
Vinuesa et al. (2005) identi"ed the M199R 
amino acid substitution in the putative E3 ubiq-
uitin ligase Roquin/Rc3h1 as the cause of the 
spontaneous lupus-like autoimmune disease char-
acterizing the sanroque mouse strain. san/san 
mice display splenomegaly, lymphadenopathy, 
plasmacytosis, spontaneous germinal center for-
mation, and glomerulonephritis with immune 
complex deposition. High a#nity anti-DNA 
autoantibodies can be detected as early as 6 wk 
after birth (Vinuesa et al., 2005). The dominant 
disease-preventing mechanism of Roquin is 
thought to be the inhibition of inappropriate 
inducible T cell co-stimulator (ICOS) expres-
sion on T cells (Linterman et al., 2009a; Yu and 
Vinuesa, 2010) through direct ICOS messen-
ger RNA (mRNA) binding and targeting to 
P-bodies and components of the decapping ma-
chinery (Athanasopoulos et al., 2010; Glasmacher 
et al., 2010). The M199R sanroque mutation is 
located in a novel protein domain termed 
ROQ, which so far has been identi"ed only in 
Roquin and its paralogue Mnab. The ROQ 
domain is critical for ICOS mRNA binding 
and repression. Because the M199R mutation 
does not a!ect binding to ICOS mRNA, it has 
been postulated that it interferes with Roquin’s 
CORRESPONDENCE  
Marc Schmidt-Supprian: 
supprian@biochem.mpg.de
Abbreviations used: ANOVA, 
analysis of variance; ES, embry-
onic stem; ICOS, inducible  
T cell co-stimulator; MFI, mean 
$uorescence intensity; mRNA, 
messenger RNA; PAS, periodic 
acid Schi!.
Loss of Roquin induces early death and 
immune deregulation but not autoimmunity
Arianna Bertossi,1 Martin Aichinger,2 Paola Sansonetti,1 Maciej Lech,3 
Frauke Ne!,4 Martin Pal,5,6 F. Thomas Wunderlich,5,6 Hans-Joachim Anders,3 
Ludger Klein,2 and Marc Schmidt-Supprian1
1Max Planck Institute of Biochemistry, 82152 Martinsried, Germany
2Institute for Immunology, Ludwig-Maximilians University, 80336 Munich, Germany
3Nephrological Center, Medical Policlinic, University of Munich, 80336 Munich, Germany
4Helmholtz Center Munich, 85764 Neuherberg, Germany
5Institute for Genetics, University of Cologne, 50674 Cologne, Germany
6Max Planck Institute for Neurological Research, 50931 Cologne, Germany
The substitution of one amino acid in the Roquin protein by the sanroque mutation induces 
a dramatic autoimmune syndrome in mice. This is believed to occur through ectopic expres-
sion of inducible T cell co-stimulator (ICOS) and unrestrained differentiation of follicular  
T helper cells, which induce spontaneous germinal center reactions to self-antigens. In this 
study, we demonstrate that tissue-speci!c ablation of Roquin in T or B cells, in the entire 
hematopoietic system, or in epithelial cells of transplanted thymi did not cause auto-
immunity. Loss of Roquin induced elevated expression of ICOS through T cell–intrinsic and  
–extrinsic mechanisms, which itself was not suf!cient to break self-tolerance. Instead, abla-
tion of Roquin in the hematopoietic system caused de!ned changes in immune homeostasis, 
including the expansion of macrophages, eosinophils, and T cell subsets, most dramatically 
CD8 effector–like T cells, through cell-autonomous and nonautonomous mechanisms. 
Germline Roquin de!ciency led to perinatal lethality, which was partially rescued on the 
genetic background of an outbred strain. However, not even complete absence of Roquin 
resulted in overt self-reactivity, suggesting that the sanroque mutation induces auto-
immunity through an as yet unknown mechanism.
© 2011 Bertossi et al. This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the !rst six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommer-
cial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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organs, there was a signi!cant increase in CD8 but not 
CD4 T cells that displayed an e"ector-like phenotype 
(CD44hiCD62Llo; Fig. 2, B and D; and Fig. S2 A). Further 
analysis of the CD44hiCD62Llo CD8 T cells revealed that most 
of them were CD127intCD122hiKLRG1hiTbethi (Fig. 2 C and 
Fig. S2 C) and therefore resembled short-lived e"ector 
cells. T?Rc3h1 mice had normal-sized spleens with regular 
follicular organization (Fig. S2, B and D), although the 
numbers of eosinophils and monocytic/macrophage pop-
ulations were doubled compared with control mice (Fig. 2 D). 
Most importantly, unlike what is seen in san/san mice (Vinuesa 
et al., 2005), we neither detected increased follicular T helper 
cell di"erentiation (Fig. S2 E) nor spontaneous germinal 
center formation (Fig. 2 E and Fig. S2 E). T?Rc3h1 mice did 
not display any obvious autoimmune manifestations, includ-
ing the production of autoantibodies (Fig. S2 F). We there-
fore conclude that the absence of Roquin speci!cally in 
T cells leads to the up-regulation of ICOS expression and 
expansion of CD8 e"ector phenotype T cells but not to 
aberrant follicular T helper cell di"erentiation or break of 
tolerance to self.
Roquin de!ciency in hematopoietic cells causes  
immune deregulation
Because T cell–speci!c ablation of Roquin was not su#cient 
to recapitulate the dramatic breakdown of self-tolerance seen 
ability to interact with as yet unknown critical e"ector pro-
teins (Athanasopoulos et al., 2010).
ICOS is an essential co-stimulatory receptor for follicular 
T helper cell di"erentiation (King et al., 2008), and hetero-
zygous ablation of ICOS (Yu et al., 2007) or depletion of 
follicular T helper cells each signi!cantly reduces the auto-
immune manifestations in san/san mice. Adoptive transfer of 
san/san follicular T helper cells induces spontaneous germinal 
center formation in recipient mice (Linterman et al., 2009b). 
Collectively, these data led to the current concept that the 
sanroque mutation induces accumulation and dysregulation of 
follicular helper T cells through T cell–intrinsic mechanisms, 
which in turn drive aberrant positive selection of autoreac-
tive B cells in the germinal center with ensuing autoimmu-
nity (Yu and Vinuesa, 2010). To study the tissue-speci!c 
function of Roquin in mouse physiology and autoimmune 
reactions, we generated a conditional Roquin knockout 
(rc3h1F) allele.
RESULTS AND DISCUSSION
Complete Roquin knockout causes perinatal lethality
To allow tissue-speci!c ablation of Roquin, we $anked 
exons 4–6 of the Rc3h1 gene with loxP sites (Fig. S1 A). The 
genetic background of the gene-targeted embryonic stem 
(ES) cells and all Cre transgenic mice used for tissue-speci!c 
gene ablation of Roquin was C57BL/6. Western blotting 
using Rc3h1F/F embryonic !broblasts, in which exons 4–6 had 
been excised by cre protein transduction, demonstrated the 
generation of a true Roquin-null mutation (Fig. 1 A). A con-
ventional Roquin knockout strain was produced through 
crosses with a germline cre-deleter strain. Roquin?/? pups 
were born at Mendelian ratios (Fig. 1 B) but died within 6 h 
after birth. Roquin?/? mice displayed a curly tail (Fig. 1 C) 
and malformations of the caudal spinal column (Fig. 1 D), 
which is often seen in mutant mice with delayed or abnor-
mal neural tube closure (Harris and Jurilo", 2007). The death 
of the animals might be related to impaired lung function 
because the alveoli were not properly expanded in the 
lungs of Roquin-de!cient pups (Fig. 1 E). Besides this, we 
could not detect obvious structural problems or indications 
of an acute respiratory distress syndrome in the lungs of 
Roquin?/? mice.
Ablation of Roquin in the T lineage leads to elevated ICOS 
levels and expansion of effector CD8 T cells but  
not autoimmunity
The lupus-like symptoms in san/san mice have been ascribed 
to a T cell–intrinsic function of Roquin (Linterman et al., 
2009a,b). To address whether ablation of Roquin speci!cally 
in T cells would recapitulate the e"ects of the sanroque muta-
tion, we generated CD4cre/Rc3h1FlF (T?Rc3h1) mice. As ex-
pected, Roquin de!ciency led to a robust up-regulation of 
ICOS on all T cell subsets in thymus and secondary lym-
phoid organs (Fig. 2 A and Fig. S1 B). Loss of Roquin 
(Fig. S1 C) did not a"ect T cell development or subset com-
position in the thymus (Fig. S1 D). In peripheral lymphoid 
Figure 1. Loss of Roquin causes perinatal lethality. (A) Western blot 
of Roquin protein expression in wild-type and Rc3h1?/? immortalized 
murine embryonic !broblasts. (B) Genotype frequency of offspring from 
intercrosses of Rc3h1+/? mice. (C) Newborn (P0) Rc3h1?/? pups show a 
curly tail. (D) PAS stainings of sagittal sections of the sacral spinal column 
of Rc3h1?/? and control newborn mice; the arrow indicates the skin, soft 
tissue, and bone defect. (E) PAS stainings of sagittal sections of lungs of 
Rc3h1?/? and control newborn mice. Bars: (D) 1 mm; (E) 50 µm.
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in san/san mice, we hypothesized that loss of Roquin in 
other hematopoietic cells might synergize with its absence in 
T cells to induce autoimmunity. We therefore generated 
VavCre/RoquinF/F (Hem?Rc3h1) mice to test the consequences 
of Roquin de!ciency in the entire hematopoietic system 
(Fig. 3 A). Hem?Rc3h1 mice displayed normal T cell develop-
ment in the thymus (Fig. S3 A), whereas BM B cell develop-
ment was a"ected through a reduction in immature and 
recirculating B cells (Fig. S3 B). Spleen size and cellular con-
tent were increased ?1.5-fold as the result of expansion of 
e"ector-like T cells, Foxp3+ regulatory T cells (Treg cells), 
eosinophils, and monocytic/macrophage populations (Fig. 3, 
B–D; and Fig. S3, C and D). However, the increased splenic 
cellularity in Hem?Rc3h1 mice did not reach the extent of sple-
nomegaly observed in san/san mice, which occurs indepen-
dently of the autoimmune syndrome (Linterman et al., 2009b). 
Analysis of splenic immune compartmentalization by immuno-
#uorescence revealed both intact and somewhat disrupted 
(Fig. 3 E) follicles in Hem?Rc3h1 mice. Moreover, we detected 
an increase in spontaneous germinal center formation in the 
spleens of Hem?Rc3h1 mice (Fig. 3 G). Analysis of Ig serum lev-
els by ELISA revealed a reduction in IgG1, IgG3, and IgA and 
an increase in IgG2b levels (Fig. S4 A). However, we did not 
detect elevated levels of autoantibodies in the serum of 
Hem?Rc3h1 mice by ELISA for typical autoantigens (Fig. 3 H 
and Fig. S4 B) or by staining of kidney, harderian gland, and 
stomach sections of Rag2?/? mice (not depicted). Importantly, 
there was no autoimmune tissue damage in kidney, liver, and 
lung of Hem?Rc3h1 mice (not depicted).
Of note, the extent of ICOS up-regulation on CD4 and, 
to a lesser extent, CD8 T cells in Hem?Rc3h1 mice exceeded 
the increase of ICOS levels in T?Rc3h1 mice (compare Fig. 3 F 
and Fig. S4 C with Fig. 2 A and Fig. S1 B). This suggests 
that the loss of Roquin in immune cells other than T cells 
contributes to the elevated ICOS expression in Hem?Rc3h1 
mice. Along the same lines, no corresponding increase of 
regulatory or e"ector-like CD4 T cells had been observed 
upon T cell–speci!c ablation of Roquin, indicating that 
these alterations re#ect a requirement for Roquin outside the 
T lineage.
Roquin-de!cient B cells contribute to the general 
deregulation of immune homeostasis
To elucidate to which extent loss of Roquin function speci!-
cally in B cells contributes to the immune activation observed 
in Hem?Rc3h1 mice, we generated CD19cre/Rc3h1F/F (B?Rc3h1) 
mice. Ablation of Roquin speci!cally in B lymphocytes 
(Fig. S4 D) was su$cient to cause enlarged spleens (Fig. S4 E) 
resulting from the expansion of B cells, Treg cells, CD4 and 
CD8 e"ector–like T cells, and eosinophils (Fig. 4 A and Fig. S4, 
F–I). There was a trend toward elevated spontaneous germi-
nal center formation in the spleens of B?Rc3h1 mice, but the 
observed di"erences were not statistically signi!cant (Fig. 4 B). 
Therefore, our !ndings show that lack of Roquin in B cells 
contributed signi!cantly to the disturbance of immune homeo-
stasis in Hem?Rc3h1 mice.
Figure 2. Roquin de!ciency in T lymphocytes leads to CD8 effector–
like T cell expansion. (A) Relative MFI of ICOS expression on CD4  
T cell subsets in the spleens of mice of the indicated genotypes. Naive, 
CD25?CD44loCD62Lhi; effector (E)-like, CD25?CD44hiCD62Llo; memory 
(Mem)-like, CD25?CD44hiCD62Lhi. Bars indicate medians of four mice per 
group, and ICOS levels on CD4cre control T cell subsets are set to 1.  
(B) Representative contour plots of T cell (TCR-?+) subsets gated as indi-
cated on the right. Numbers represent percentages of the gated popula-
tions of the indicated T cell subtype. (C) Histogram of KLRG1 and Tbet 
expression on CD44hiCD62Llo-gated effector-like CD8 T cells, representative 
of !ve experiments. (D) Bar charts of absolute numbers of indicated T cell 
(TCR-?+; subsets as in A) and myeloid cell subsets: Eos, eosinophils  
(Gr1intSiglecF+); Mono/Mac, monocytes/macrophages (SiglecF?Gr1intMac1+). 
Columns and error bars indicate means ± SD calculated from six to nine 
mice per genotype. (E) Absolute numbers of splenic germinal center (GC; 
B220+PNAhiFashiCD38lo) B cells of 11–6 mice per genotype. Bars indicate 
the median. *, P < 0.05; **, P < 0.001; one-way ANOVA.
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Roquin-su!cient hematopoietic system, and T cells were 
selected on either Roquin-deficient (Rc3h1?/? → nude) 
or -su!cient (Rc3h1+/+ → nude) thymic epithelium. Recipients 
of Roquin-de"cient thymic epithelium gained weight nor-
mally after transplantation (Fig. 5 A) and did not show signs 
of disease by histological criteria (not depicted). Embryonic 
day (E) 16.5 Rc3h1?/? thymic lobes at the time of grafting 
appeared somewhat smaller than Rc3h1+/+ controls, and the 
cellularity of Rc3h1?/? thymi 10 wk after transplantation was 
signi"cantly reduced compared with controls (Fig. 5 B). Despite 
this thymic atrophy, which points to a thymic epithelium– 
intrinsic function of Roquin in epithelial homeostasis, thymo-
cyte development was not a#ected (Fig. 5 C). T cell selection 
was also una#ected, as judged from the normal numbers of 
Roquin de!ciency in thymic epithelial cells causes thymic 
atrophy but does not affect T cell selection
Loss of Roquin in hematopoietic cells does not cause a dra-
matic sanroque-like autoimmune syndrome. We therefore hy-
pothesized that Roquin-de"cient nonhematopoietic cells might 
be crucial for the induction of autoimmunity. The thymic 
epithelium plays a critical role for immune tolerance, and per-
turbations of its development and/or function can lead to 
spontaneous autoimmunity (Kyewski and Klein, 2006). To 
assess the function of Roquin speci"cally in thymic epithelial 
cells during thymocyte development and selection, we trans-
planted immune cell–depleted Roquin-de"cient and control 
embryonic thymi under the kidney capsule of athymic C57BL/6 
nude mice. As a consequence, these chimeras contained a 
Figure 3. Deregulation of immune homeostasis in the absence of Roquin in the hematopoietic system. (A) Western blot analysis to evaluate 
Roquin protein expression in splenocytes. (B and C) Absolute cell numbers (B) and representative contour plots (C) of splenic T cell (TCR-?+) subsets:  
effector (E)-like, CD44hiCD62Llo; and memory (Mem)-like, CD44hiCD62Lhi (n = 7–9); Treg cells, CD4+FoxP3+ (n = 3–5). Columns and error bars represent 
means ± SD calculated from the number of mice indicated. (D) Columns and error bars represent means ± SD of absolute cell numbers of eosinophils (Eos;  
Gr1intSiglecF+) and monocytic/macrophages (Mono/Mac; SiglecF?Gr1intMac1+) calculated from four to six mice per group. (E) Immuno!uorescence of 
spleen sections: green, ?-B220; red, ?-CD3; blue, ?-laminin. Bars, 100 µm. (F) Relative ICOS MFI of naive (CD44lo) and memory/effector-like (CD44hi) 
splenic CD4 T cells. Bars indicate medians. (G) Absolute cell numbers of germinal center (GC; B220+PNAhiFashiCD38lo) B cells. Bars represent medians cal-
culated from "ve to seven mice per genotype. (H) Titers of serum autoantibodies against nucleosomes measured by ELISA (2–7 mo old) from 8–10 mice of 
the indicated genotypes. Sera from BL/6, IRF4?/?-lpr, BL/6-lpr, and MRL-lpr mice were used as positive or negative controls. Columns and error bars rep-
resent means ± SD. *, P < 0.05; **, P < 0.001; one-way ANOVA.
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numbers of eosinophils and monocytic/macrophage popula-
tions (Fig. 6 C and Fig. S6 C). However, the most prominent 
e!ect was a dramatic and selective expansion of Roquin- 
de"cient CD8 e!ector–like T cells (Fig. 6 C), showing that 
suppressing the generation of these cells is a dominant function 
of Roquin in naive mice. Splenic follicular organization 
was normal (Fig. 6 D), and the numbers of CD4 T cell sub-
types and B cells (Fig. S6 D) were not signi"cantly altered in 
CD1 Roquin?/? mice. In addition, we did not detect spon-
taneous germinal center formation (Fig. 6 E), autoantibody 
production (Fig. 6 F and Fig. S6 E), or autoimmune tissue 
damage in CD1 Roquin?/? mice (not depicted).
We show in this study that, unlike the sanroque mutation, 
systemic ablation of Roquin causes perinatal lethality, reveal-
ing a hitherto unappreciated critical role of Rc3h1 outside 
the immune system. In immune cells, loss of Roquin induces 
several de"ned perturbations. De"ciency in B cells leads to 
elevated numbers of B, regulatory and e!ector-like T cells, and 
eosinophils. Roquin deletion in T cells induces the expan-
sion of eosinophils and macrophages and the dramatic spon-
taneous di!erentiation of e!ector-like CD8 T cells. Our "ndings 
peripheral T cell subsets (Fig. S5 A) and normal proportions 
of TCRs bearing certain ? and ? chains (Fig. 5 D and Fig. S5 B). 
These data show that although absence of Roquin in the 
thymic epithelium reduced thymus size under these experi-
mental conditions, it did not a!ect T cell selection or allow the 
escape of self-reactive T cells.
CD1 outbred Roquin?/? mice survive at sub-Mendelian 
ratios and display growth retardation and relatively mild 
immune defects
To overcome the perinatal lethality that prevents the analysis 
of adult C57BL/6 Roquin-de"cient mice, we crossed C57BL/6 
Roquin+/? mice onto a CD1 outbred background. 4% of 
CD1 Roquin?/? mice survived to adulthood (Fig. 6 A) in 
heterozygous crosses, displaying growth retardation (Fig. 6 B) 
and the typical curly tail at birth, which was sometimes cor-
rected later on (Fig. S6 A). In general, the immune pheno-
types were somewhat milder in CD1 Roquin?/? than in 
C57BL/6 Hem?Rc3h1 mice, most likely because of the CD1 
outbred background. CD1 Roquin?/? mice displayed en-
larged spleens (Fig. S6 B) with a trend toward increased 
Figure 4. Roquin-de!cient B cells cause effector-like T cell expansion. (A) Column and error bars represent means ± SD of absolute cell numbers 
of splenocytes (n = 8), B cells (B220+; n = 8), Treg cells (CD4+FoxP3+; n = 4), CD4 effector (E)–like T cells (CD25?CD44hiCD62Llo; n = 4), CD8 effector–like T cells 
(CD44hiCD62Llo; n = 4), and eosinophils (Eos; Gr1intSiglecF+; n = 8). (B) Absolute cell numbers of germinal center (GC; B220+FashiPNAhiCD38lo) B cells. Bars 
indicate medians calculated from six to eight mice per group. *, P < 0.05; **, P < 0.001; one-way ANOVA.
Figure 5. Effect of Roquin loss in thymic 
epithelial cells. (A) Growth curve of nude 
mice transplanted with fetal thymic epithe-
lium as indicated. Means ± SD for recipients 
of six wild-type and six Rc3h1?/? thymi are 
shown. (B) Rc3h1+/+ and Rc3h1?/? thymic 
epithelium–derived thymus lobes on kidneys 
of C57BL/6 nude mice 10 wk after transplan-
tation. Bar chart shows absolute numbers of 
thymocytes. Bars, 500 µm. (C) Proportions of 
thymocyte subsets. DN, (CD4/CD8) double 
negative; DP, double positive; SP, single posi-
tive; Treg cells, CD4+FoxP3+. (D) Usage of indi-
vidual V? (left) and V? (right) chains in the 
TCR on CD4 T cells in mice of the indicated 
genotypes. (B–D) Columns and error bars 
represent means ± SD of !ve to six mice per 
group. **, P < 0.001; Student’s t test.
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by some means. However, it seems more likely that the san-
roque mutation causes to date unidenti!ed perturbations, which 
are not recapitulated by the absence of Roquin. In this sce-
nario, another protein such as the Roquin paralogue Mnab 
might compensate for the absence of Roquin, which it cannot 
do in the presence of RoquinM199R. Therefore, the presence of 
RoquinM199R in protein complexes might be more disruptive 
than the absence of the protein. This hypothesis is supported 
by the fact that heterozygous C57BL/6 san/WT (Vinuesa 
et al., 2005), but not C57BL/6 Roquin+/? (Fig. S6 F) ani-
mals develop antinuclear autoantibodies. Be this as it may, 
our !ndings show that to bring about a spontaneous failure of 
immune tolerance, a complex and as yet ill-de!ned interplay 
of Roquin absence or malfunction in various cell types may 
be required.
MATERIALS AND METHODS
Genetically modi!ed mice. To generate a conditional rc3h1 allele, we 
cloned a targeting vector to "ank exons 4–6 with loxP sites. An Frt site–
"anked neoR cassette was placed in the third intron of the Rc3h1 gene. A 4.0-kb 
fragment was used as the 5? homology region, a 2-kb fragment was placed be-
tween the two loxP sites, and a 4.0-kb fragment was used as the 3? homology 
region. C57BL/6 ES cells were transfected, cultured, and selected essentially 
as previously described for Bruce 4 ES cells (Schmidt-Supprian et al., 2000). 
After blastocyst injection of correctly targeted clones and transmission of the 
conditional allele through the germline of resulting chimeras, the Frt-"anked 
neoR cassette was removed by using an Flpe-deleter strain. Rc3h1F, Nestin-cre 
(used as deleter mice; Betz et al., 1996), Flpe-deleter (Rodríguez et al., 2000), 
CD4cre (Lee et al., 2001), VavCre (de Boer et al., 2003), and CD19cre 
(Rickert et al., 1997) were kept on a C57BL/6 genetic background. All mice 
analyzed were 2–4 mo old, unless otherwise indicated. CD1 outbred mice 
were kept at the Max Planck Institute of Biochemistry (MpiCrlIcr:CD-1). 
Mice were housed in the speci!c pathogen–free animal facility of the Max 
Planck Institute of Biochemistry. All animal procedures were approved by the 
Regierung of Oberbayern.
Flow cytometry. Single-cell suspensions were prepared and stained with 
monoclonal antibodies: PD-1 (J43), ICOS (7E.17G9), B220 (RA3-6B2), 
CD19 (eBio1D3), CD25 (PC61.5), CD38 (90), CD4 (RM4-5), CD44 (IM7), 
CD5 (53-7.3), CD62L (MEL-14), CD8 (53-6.7), FoxP3 (FJK-16s), GR-1 
(RB6-8C5), IgD (11–26), IgM (II/41), Mac-1 (M1/70), TCR-? (H57-597), 
CD95 (15A7), CD21 (7G6), c-kit (2B8), KLRG1 (2F1), CD127 (A7R34), 
CD122 (TM-b1), Tbet (eBio4B10), F4/80 (A3-1), CD115 (AFS98), 
CD45RB (C363.16A; all eBioscience), Siglec-F (E50-2440), CD138 (281-2), 
CXCR5 (2G8), CD11c (HL3), V?11.1/11.2 (RR8-1), V?2 (B20.1), V?3.2 
(RR3-16), V?8.3 (B21.14), TCR V? screening panel (all BD), and PNA 
(Vector Laboratories). Samples were acquired on FACSCalibur and FACS-
CantoII (BD) machines and analyzed with FlowJo software (Tree Star). To 
evaluate the relative ICOS expression on T cell subsets of the di#erent cell 
type–speci!c Roquin knockout mice, four sets of three genotypes (cre con-
trol, heterozygous knockout, and homozygous knockout) were analyzed. The 
ICOS mean "uorescence intensity (MFI) for the cre transgenic control cells 
was set to 1 for each set.
Cell culture. We generated primary and SV40 large T–immortalized Rc3h1F/F 
and control embryonic !broblasts and treated them by cre protein transduc-
tion with Histag-tat-NLS-cre (Peitz et al., 2007).
Western blot. To prepare whole-cell lysates, cells were lysed for 15 min on ice 
by RIPA bu#er, 10 µg/ml aprotinin, 10 µg/ml leupeptin, 0.1 mM Na3VO4, 
1 mM PMSF, 10 mM NaF, 1 mM DTT, and 8 mM ?-glycerophosphate. 
Polyvinylidene "uoride membranes were blotted with the following anti-
bodies: anti-Rc3h1 (Bethyl Laboratories, Inc.), antitubulin (clone YL1/2; 
clearly demonstrate that ablation of Roquin, although it aug-
ments ICOS expression levels through T cell–autonomous 
and nonautonomous mechanisms, is not su$cient to cause 
autoimmunity. It remains possible that C57BL/6 complete 
Roquin knockout mice would develop a sanroque-like auto-
immune syndrome if the perinatal lethality could be overcome 
Figure 6. Roquin knockout mice can survive on a CD1 outbred 
genetic background. (A) Genotype frequency of offspring of hetero-
zygous matings of CD1 Rc3h1+/? mice. (B) Body weight curve of Rc3h1?/? 
mice compared with control littermates (2–21 mice per group and time 
point). Error bars indicate SD. (C and E) Absolute cell numbers of eosino-
phils (Eos; Gr1intSiglec-F+), monocytic/macrophages (Mono/Mac; 
SiglecF?Gr1intMac1+), splenic CD8+ T cell subsets (Effector [E]-like,  
CD44hiCD62Llo; memory (Mem)-like, CD44hiCD62Lhi; C) and germinal 
center (GC; B220+PNAhiFashiCD38lo) B cells (E) calculated from six mice 
of the indicated genotypes. Bars represent medians. (D) Immuno!uores-
cence of spleen sections: green, ?-B220; red, ?-CD3; blue, ?-laminin. 
Bars, 100 µm. (F) Titers of autoantibodies against nucleosomes detected 
by ELISA in the serum of eight to nine 2.5–3.5-mo-old mice of the indi-
cated genotypes. Columns and error bars indicate means ± SD.  
**, P < 0.001; one-way ANOVA.
 o
n
 A
u
g
u
s
t 1
5
, 2
0
1
1
je
m
.ru
p
re
s
s
.o
rg
D
o
w
n
lo
a
d
e
d
 fro
m
 
Published August 15, 2011
JEM 7 of 8
Br ief Definit ive Repor t
We thank Christoph Vahl for cell sorting and Vigo Heissmeyer for advice. We are 
grateful to Reinhard Fässler for support. We wish to thank Julia Knogler, Barbara 
Habermehl, and Elenore Samson for technical assistance. We are indebted to Vigo 
Heissmeyer, Klaus Heger, Christoph Vahl, and Yuanyuan Chu for critical reading of 
the manuscript.
This study was supported by Emmy Noether grant SCHM2440 from the 
Deutsche Forschungsgemeinschaft (DFG) and a grant from the Thyssen Foundation 
to M. Schmidt-Supprian. H.-J. Anders was supported by DFG grant AN372/10-1, and 
M. Aichinger and L. Klein were supported by DFG grant KL1228/2-1.
The authors have no con!icting "nancial interests.
Submitted: 23 March 2011
Accepted: 21 July 2011
REFERENCES
Athanasopoulos, V., A. Barker, D. Yu, A.H. Tan, M. Srivastava, N. 
Contreras, J. Wang, K.P. Lam, S.H. Brown, C.C. Goodnow, et al. 
2010. The ROQUIN family of proteins localizes to stress granules via 
the ROQ domain and binds target mRNAs. FEBS J. 277:2109–2127. 
doi:10.1111/j.1742-4658.2010.07628.x
Betz, U.A., C.A. Vosshenrich, K. Rajewsky, and W. Müller. 1996. Bypass of 
lethality with mosaic mice generated by Cre-loxP-mediated recombina-
tion. Curr. Biol. 6:1307–1316. doi:10.1016/S0960-9822(02)70717-3
de Boer, J., A. Williams, G. Skavdis, N. Harker, M. Coles, M. Tolaini, T. 
Norton, K. Williams, K. Roderick, A.J. Potocnik, and D. Kioussis. 2003. 
Transgenic mice with hematopoietic and lymphoid speci!c expression 
of Cre. Eur. J. Immunol. 33:314–325. doi:10.1002/immu.200310005
Glasmacher, E., K.P. Hoe!g, K.U. Vogel, N. Rath, L. Du, C. Wolf, E. 
Kremmer, X. Wang, and V. Heissmeyer. 2010. Roquin binds inducible 
costimulator mRNA and e"ectors of mRNA decay to induce microRNA-
independent post-transcriptional repression. Nat. Immunol. 11:725–733. 
doi:10.1038/ni.1902
Goodnow, C.C. 2007. Multistep pathogenesis of autoimmune disease. Cell. 
130:25–35. doi:10.1016/j.cell.2007.06.033
Harris, M.J., and D.M. Jurilo". 2007. Mouse mutants with neural tube closure 
defects and their role in understanding human neural tube defects. Birth 
Defects Res. A Clin. Mol. Teratol. 79:187–210. doi:10.1002/bdra.20333
King, C., S.G. Tangye, and C.R. Mackay. 2008. T follicular helper (TFH) 
cells in normal and dysregulated immune responses. Annu. Rev. Immunol. 
26:741–766. doi:10.1146/annurev.immunol.26.021607.090344
Kyewski, B., and L. Klein. 2006. A central role for central tolerance. 
Annu. Rev. Immunol. 24:571–606. doi:10.1146/annurev.immunol.23 
.021704.115601
Lech, M., O.P. Kulkarni, S. Pfei"er, E. Savarese, A. Krug, C. Garlanda, A. 
Mantovani, and H.J. Anders. 2008. Tir8/Sigirr prevents murine lupus 
by suppressing the immunostimulatory e"ects of lupus autoantigens. 
J. Exp. Med. 205:1879–1888. doi:10.1084/jem.20072646
Lee, P.P., D.R. Fitzpatrick, C. Beard, H.K. Jessup, S. Lehar, K.W. Makar, M. 
Pérez-Melgosa, M.T. Sweetser, M.S. Schlissel, S. Nguyen, et al. 2001. 
A critical role for Dnmt1 and DNA methylation in T cell development, 
function, and survival. Immunity. 15:763–774. doi:10.1016/S1074- 
7613(01)00227-8
Linterman, M.A., R.J. Rigby, R. Wong, D. Silva, D. Withers, G. Anderson, 
N.K. Verma, R. Brink, A. Hutlo", C.C. Goodnow, and C.G. Vinuesa. 
2009a. Roquin di"erentiates the specialized functions of duplicated T cell 
costimulatory receptor genes CD28 and ICOS. Immunity. 30:228–241. 
doi:10.1016/j.immuni.2008.12.015
Linterman, M.A., R.J. Rigby, R.K. Wong, D. Yu, R. Brink, J.L. Cannons, 
P.L. Schwartzberg, M.C. Cook, G.D. Walters, and C.G. Vinuesa. 
2009b. Follicular helper T cells are required for systemic autoimmunity. 
J. Exp. Med. 206:561–576. doi:10.1084/jem.20081886
Peitz, M., R. Jäger, C. Patsch, A. Jäger, A. Egert, H. Schorle, and F. 
Edenhofer. 2007. Enhanced puri!cation of cell-permeant Cre and germ-
line transmission after transduction into mouse embryonic stem cells. 
Genesis. 45:508–517. doi:10.1002/dvg.20321
Rickert, R.C., J. Roes, and K. Rajewsky. 1997. B lymphocyte-speci!c, 
Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25:1317–1318. 
doi:10.1093/nar/25.6.1317
Millipore), antiactinin (clone AT6/172; Millipore), and anti-GAPDH (clone 
6C5; EMD).
Immuno!uorescence and immunohistochemistry. For immuno#uores-
cence stainings, frozen 10-µm sections were thawed, air dried, methanol 
!xed, and stained for 1 h at room temperature in a humidi!ed chamber with 
FITC-conjugated B220 (eBioscience), biotinylated rat anti-CD3 (BD), and 
rabbit antilaminin (gift from M. Sixt, Institute of Science and Technology 
Austria, Klosterneuburg, Austria) followed by Alexa Fluor 488–conjugated 
anti#uorescein (Invitrogen), Cy3-conjugated streptavidin (Jackson Immuno-
Research Laboratories, Inc.), and Cy5-conjugated anti–rabbit antibodies 
(Jackson ImmunoResearch Laboratories, Inc.). Images were acquired using an 
Axio Imager.Z1 #uorescent microscope (Carl Zeiss) with AxioCam MRc5 
(Carl Zeiss) and analyzed with AxioVision Rel. 4.8 software (Carl Zeiss).
Histology. Whole embryos or newborn pups were !xed for 24 h in 4% 
paraformaldehyde and decalci!ed for 4 h in Osteosoft (Merck), and heads 
and whole embryos were cut sagittally at the midline. Dehydration and 
para$n embedding were performed using a vacuum embedding system 
(VIP; Sakura). Para$n slides were performed with 4-µm thickness and 
stained with hematoxylin and eosin and periodic acid Schiff (PAS). 
Images were taken using a virtual slide microscopy system (dotslide 
2.0; Olympus).
ELISA. Antinuclear autoantibodies to eight di"erent autoantigens were 
detected using the Varelisa ANA 8 screen (Phadia). Serum from a 1-yr-old 
BXD2 mouse was used as positive control. The following ELISAs were per-
formed as described previously (Lech et al., 2008). For antinucleosome anti-
bodies, MaxiSorp ELISA plates (Thermo Fisher Scienti!c) were precoated 
with poly-l-lysine (Trevigen) and PBS (ratio 1:1) for 1 h. ELISA plates were 
washed with 50 mM Tris and 0.14 M NaCl bu"er and incubated with 
mouse double-stranded DNA–histones (both 2 µg/ml) in SSC bu"er over-
night at 4°C. For anti-Smith antibodies, MaxiSorp ELISA plates were coated 
with Smith antigen (Immunovision) in 0.05 M carbonate-bicarbonate bu"er 
overnight at 4°C. For rheumatoid factor, ELISA plates were coated with 
10 µg/ml rabbit IgG (Jackson ImmunoResearch Laboratories, Inc.) in 0.05 M 
carbonate-bicarbonate bu"er overnight at 4°C. Serum samples were diluted 
1:10 for all IgG ELISAs. 24-wk C57BL/6 wild-type and antibody-poor 
(IRF-4?/?BL/6lpr) serum was used as negative controls. C57BL/6-lpr and 
MRL-lpr 24-wk mouse serum was used as positive control. Speci!c IgGs 
were detected by horseradish peroxidase–conjugated goat anti–mouse IgG 
(Bethyl Laboratories, Inc.).
Transplantation of thymic epithelial cells. Embryonic thymic lobes (E16.5) 
were placed onto Isopore membrane !lters (Millipore), #oating on 3 ml dGuo 
medium (IMDM) supplemented with 1.35 mM deoxyguanosine (Sigma-
Aldrich) and 10% vol/vol FCS (Invitrogen) and cultured for 5 d. After dGuo 
treatment, the lobes were washed in PBS and transplanted underneath the 
kidney capsules of athymic C57BL/6 nude mice (Taconic).
Statistics. Statistical analysis of the results was performed by one-way analy-
sis of variance (ANOVA) followed by Tukey’s test or by Student’s t test. 
P-values are presented in !gure legends where a statistically signi!cant dif-
ference was found.
Online supplemental material. Fig. S1 shows the targeting strategy for 
the rc3h1FL allele and ablation of Roquin in T cells. Figs. S2, S3, and S4 show 
the e"ects of T cell (Fig. S2)–, hematopoietic system (Figs. S3 and S4)–, and 
B cell–speci!c (Fig. S4) ablation of Roquin. Fig. S5 shows T cell develop-
ment and selection in nude mice transplanted with Rc3h1?/? and control 
fetal thymic epithelial cells. Fig. S6 shows that outbred CD1 Roquin?/? 
mice display growth retardation and immune deregulation. Supplemental 
material and methods describe the preparation and staining of cytospins 
and ELISA. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20110578/DC1.
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 Figure S1.  Conditional targeting strategy of the  Rc3h1 allele and ablation of Roquin in T cells. (A) Schematic representation of the gene target-
ing construct, the screening strategy used to generate the loxP-! anked  rc3h1 allele (left), and Southern blot of BamHI-digested ES cell DNA showing the 
targeted allele (right). (B, top) Relative ICOS MFI in different T cell subsets. Thymocyte subsets (top left): DP, CD4/CD8 double positive; SP, single positive. 
Splenic T cells (top right): naive, CD44 lo CD62L hi ; effector (E)-like, CD44 hi CD62L lo ; memory (Mem)-like, CD44 hi CD62L hi . Bars indicate medians. (bottom) Rep-
resentative histograms showing ICOS levels on the indicated splenic T cell subsets. (C) Western blot for Roquin in sorted TCR- ! + splenocytes of mice of 
the indicated genotypes. The arrow indicates Roquin, and the asterisk indicates an unspeci" c band. (D) Absolute numbers of thymocyte subsets calculated 
from six to eight mice per genotype: DN, CD4/CD8 double negative; DP, double positive; SP, single positive. Bars represent medians. *, P < 0.05; **, P < 
0.001; one-way ANOVA. 
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 Figure S2.  Effects of T cell–speci! c ablation of Roquin. (A) Bar charts of absolute numbers of splenic CD4 T cell subsets: T reg cells, FoxP3 + ; naive, 
CD25  !  CD44 lo CD62L hi ; effector (E)-like, CD25  !  CD44 hi CD62L lo ; memory (Mem)-like, CD25  !  CD44 hi CD62L hi . Columns and error bars represent means ± SD of 
four to nine mice per genotype. (B) Bar charts of absolute numbers of splenocytes, neutrophils (Neu; Mac1 + Gr1 hi SiglecF  !  ), and DCs (CD11c + ) calculated 
from six to eight mice of the indicated genotypes. Columns and error bars represent means ± SD. (C) Representative histograms showing KLRG1, CD127, 
CD122, and Tbet expression levels on the indicated splenic CD8 T cell subsets ( n = 4–5). (D) Immuno! uorescence of spleen sections: green,  " -B220; red, 
 " -CD3; blue,  " -laminin. Bars, 100 µm. (E) Contour plots of the proportions of follicular T helper cells (PD-1 hi CXCR5 hi ;  n = 5) in CD4 T cells and of germinal 
center B cells (GCB; Fas hi CD38 lo ;  n = 5) in B cells;  n refers to the number of mice per genotype analyzed. Numbers next to the gates indicate medians, and 
numbers in parentheses indicate upper and lower limits. Cell # indicates median of absolute cell numbers of follicular T helper cells in spleens of mice of 
the indicated genotypes, and numbers in parentheses indicate upper and lower limits ( n = 5). Peyer’s patches from BL/6 mice were used as staining posi-
tive control. (F) Titers of autoantibodies against nucleosomes, endogenous IgG (rheumatoid factor), Smith antigen (RNA), and eight different nuclear au-
toantigens (8x ANA) were determined in the serum of 3–10-mo-old mice of the indicated genotypes by ELISA. Columns and error bars represent means ± 
SD of 9–12 mice per group. Sera from BL/6, IRF4  ! / !  -lpr, BXD2, BL/6-lpr, and MRL-lpr mice were used as positive or negative controls. 
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 Figure S3.  Effects of a Roquin-de! cient hematopoietic system. (A and B) Absolute cell numbers of total thymocytes and of thymocyte subsets (A) 
and of total BM cells and BM B cell subsets (B) calculated from ! ve to nine mice per genotype. DN, CD4/CD8 double negative; DP, double positive; SP, 
single positive; pro B, B220 lo IgM  !  CD25  !  c-Kit + ; pre B, B220 lo IgM  !  CD25 + c-Kit  !  ; immature (Imm) B, B220 lo IgM + ; recirculating (Recirc) B, B220 hi IgM + . Col-
umns and error bars represent means ± SD. (C) Representative spleen sizes (top left) and weight calculated from seven to nine mice per genotype (bottom 
left). (right) Total splenocyte ( n = 9–11), B cell (B220 + ;  n = 9–11), naive CD4 and CD8 T cell (CD44 lo CD62L hi ;  n = 9–7), neutrophil (Neu; Mac1 + Gr1 hi SiglecF  !  ; 
 n = 4–6), and DC (CD11c + ;  n = 4–6) numbers in spleens of mice of the indicated genotypes. Error bars indicate SD. (D) Representative contour plots (top) 
showing the gating strategy for eosinophils (Gr1 int Siglec-F + ), neutrophils (Mac1 + Gr1 hi SiglecF  !  ), and monocytes/macrophages (Mono/Mac; 
Gr1 int Mac1 + SiglecF  !  ). Representative histograms (third row) showing F4/80 and CD115 expression levels on the indicated cell subsets. SSC-A/FSC-A dot 
plot (second row) of eosinophils, macrophages/monocytes and neutrophils. Numbers next to gates indicate percentage; data are representative for four 
mice per genotype. (bottom) Cytospin of FACS-sorted eosinophils (Gr1 int SiglecF hi ) and macrophages/monocytes (Gr1 int Mac1 + SiglecF  !  ) from spleens of 
mice of the indicated genotypes stained using Hemacolor rapid staining. Bars, 10 µm. *, P < 0.05; **, P < 0.001; one-way ANOVA. 
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 Figure S4.  Roquin-de! cient B cells cause deregulation of immune homeostasis. (A) Total levels of the indicated Igs in serum of naive mice of the 
indicated genotypes. Bars indicate mean of ! ve to eight mice per genotype. (B) Titers of antibodies against Smith antigen ( n = 8–10), rheumatoid factor 
( n = 8–10), and eight different nuclear autoantigens (8x ANA;  n = 4–6) in serum from 2–7-mo-old mice of the indicated genotype. Sera from BL/6, 
IRF4  ! / !  -lpr, BXD2, BL/6-lpr, and MRL-lpr mice were used as positive or negative controls. Error bars indicate SD. (C) Relative ICOS MFI on the indicated 
splenic T cells subsets. Mice were analyzed in four sets of three genotypes, and the ICOS MFI for the VavCre control cells was set to 1 for each set. Bars 
indicate the median. (D) Western blot for Roquin protein levels in CD43  !  splenocytes of mice of the indicated genotypes. (E) Representative spleen sizes 
(top) and spleen weight (bottom) calculated from eight mice per group. Columns and error bars indicate means ± SD. (F) Contour plots showing the pro-
portions of T reg cells (FoxP3 + ) of CD4 T cells in the spleens of the indicated mice. (G) Representative histograms showing CD122 and CD45RB expression 
levels on the indicated subsets of splenocytes from control (top) or B  " Rc3h1 (bottom) mice ( n = 4). (H and I) Absolute cell numbers of naive (CD44 lo CD62L hi ) 
and memory (Mem)-like (CD44 hi CD62L hi ) CD4 (H, left) and CD8 (H, right) T cells and splenic myeloid cells (I); Neu, neutrophils (Mac1 + Gr1 hi SiglecF  !  ); Mono/
Mac, monocytes/macrophages (Gr1 int Mac1 + SiglecF  !  ); DC, CD11c + . Columns and error bars indicate means ± SD of four to eight mice per genotype. *, P < 
0.05; **, P < 0.001; one-way ANOVA. 
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 Figure S5.  Normal T cell development and selection in nude mice transplanted with  Rc3h1  ! / !  fetal thymic epithelial cells. (A) Absolute num-
bers of splenocytes and splenic CD4 and CD8 T cells subsets calculated from ! ve to six mice per genotype. T reg cells, CD4 + FoxP3 + ; naive, CD44 lo CD62L hi ; 
effector (E)-like, CD44 hi CD62L lo ; memory (Mem)-like, CD44 hi CD62L hi . (B) Proportions of v ! - (top) and v " - (bottom) TCR chain usage in splenic CD8 T cells. 
(A and B) Columns and error bars represent means ± SD of ! ve to six mice per group. 
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 Figure S6.  Growth retardation and immune phenotypes of CD1 Rc3h1  ! / !  mice. (A) Pictures of 3-mo-old CD1 Rc3h1  ! / !  mice and littermate con-
trols. (B) Representative spleen sizes of 2–3-mo-old mice (top). Mean spleen weight calculated from six mice of the indicated genotypes (bottom). Error 
bars indicate SD. (C and D) Absolute cell numbers of splenocytes, neutrophils (Neu; Mac1 + Gr1 hi Siglec-F  !  ), and DCs (CD11c + ; C) and B cells, CD4 T cells 
subsets (T reg cells, CD4 + FoxP3 hi ; naive, CD25  !  CD44 lo CD62L hi ; effector [E]–like, CD25  !  CD44 hi CD62L lo ; memory [Mem]-like, CD25  !  CD44 hi CD62L hi ) and naive 
(CD44 lo CD62L hi ) CD8 T cells (D) in ! ve to six mice of the indicated genotype. Bars represent medians. (E) Serum titers of antibodies against eight prevalent 
nuclear autoantigens (8x ANA), Smith antigen, and endogenous IgG (rheumatoid factor) were determined in 2.5–3.5-mo-old mice of the indicated geno-
type by ELISA. Columns and error bars represent means ± SD of eight to nine mice per group. Sera from BL/6, IRF4  ! / !  -lpr, BXD2, BL/6-lpr, and MRL-lpr 
were used as positive or negative controls. (F) Serum titers of antibodies against eight prevalent nuclear autoantigens in 10 C57BL/6 (four males at 5–15 
mo and six females at 3–9 mo) and 10 C57BL/6 Roquin +/ !  mice (seven males at 3–8 mo and three females at 4–6 mo). Sera from a BXD2 mouse was used 
as a positive control. Bars indicate the mean. **, P < 0.001; one-way ANOVA. 
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 SUPPLEMENTAL MATERIALS AND METHODS 
 Cytology.  A cytospin was prepared by using Shandon Cytospin4 (Thermo Fisher Scienti! c). The staining was performed by using Hemacolor Stain Solution 
(Merck) according to the manufacturer’s instructions. Images were acquired using a microscope (Axioskop; Carl Zeiss) with a camera (DC500; Leica). 
 ELISA.  Serum Ig concentrations were determined by ELISA as described previously ( Schmidt-Supprian et al., 2004 ). 
 REFERENCE 
 Schmidt-Supprian ,  M. ,  J.  Tian ,  H.  Ji ,  C.  Terhorst ,  A.K.  Bhan ,  E.P.  Grant ,  M.  Pasparakis ,  S.  Casola ,  A.J.  Coyle , and  K.  Rajewsky .  2004 .  I kappa B kinase 2 
de! ciency in T cells leads to defects in priming, B cell help, germinal center reactions, and homeostatic expansion .  J. Immunol.  173 : 1612 – 1619 . 
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